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ABSTRACT OF DISSERTATION 
 
 
 
 
 
REGULATION OF L-TYPE VOLTAGE-DEPENDNET CALCIUM 
CHANNELS BY THE REM GTPASE 
 
 
        The Rem, Rem2, Rad, and Gem/Kir GTPases, comprise a novel subfamily of the 
small Ras-related GTP-binding proteins known as the RGK GTPases, and have been 
shown to function as potent negative regulators of high voltage-activated (HVA) Ca2+ 
channels upon overexpression. HVA Ca2+ channels modulate Ca2+ influx in response to 
membrane depolarization to regulate a wide variety of cellular functions and they 
minimally consist of a pore-forming α1 subunit, an intracellular β subunit, and a 
transmembrane complex α2/δ subunit. While the mechanisms underlying RGK-mediated 
Ca2+ channel regulation remain poorly defined, it appears that both membrane 
localization and the binding of accessory Ca2+ channel β subunits (CaVβ) are required for 
suppression of Ca2+ channel currents. We identified a direct interaction between Rem and 
the L-type Cavα1 C-terminus (CCT), but not the CCT from CaV3.2 T-type channels. 
Deletion mapping studies suggest that the conserved CB-IQ domain is required for 
Rem:CCT association, a region known to contribute to both Ca2+-dependent channel 
inactivation and facilitation through interactions of Ca2+-bound calmodulin (CaM) with 
the proximal CCT. Furthermore, both Rem2 and Rad GTPases display similar patterns of 
CCT binding, suggesting that CCT represents a common binding partner for all RGK 
proteins. While previous studies have found that association of the Rem C-terminus with 
the plasma membrane is required for channel inhibition, it is not required for CaVβ-
subunit binding. However, Rem:CCT association is well correlated with the plasma 
membrane localization of Rem and more importantly, Rem-mediated channel inhibition 
upon overexpression. Moreover, co-expression of the proximal CB-IQ containing region 
of CCT (residues 1507-1669) in HIT-T15 cells partially relieves Rem blockade of ionic 
current. Interestingly, Ca2+/CaM disrupts Rem:CCT association in vitro. Moreover, CaM 
overexpression partially relieves Rem-mediated L-type Ca2+ channel inhibition and Rem 
overexpression alters the kinetics of calcium-dependent inactivation. Together, these data 
suggest that the association of Rem with the CCT represents a crucial molecular 
determinant for Rem-mediated L-type Ca2+ channel regulation and provides new insights 
into this novel channel regulatory process. These studies also suggest that instead of 
acting as complete Ca2+ channel blockers, RGK proteins may function as endogenous 
regulators for the channel inactivation machinery.  
 
 
Keywords: RGK GTPase, Voltage-dependent calcium channels, Cavα1 C-terminus (CCT), 
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Chapter 1. RGK GTPases: Regulators of Cytoskeleton Reorganization 
and Voltage-Dependent Calcium Channels  
 
1. 1 Introduction 
As essential players in orchestrating the signaling pathways in a wide spectrum of 
normal physiology, the Ras GTPases are monomeric small GTP-binding proteins  
consisting of approximately 170 members [1]. Based on their structural and functional 
similarities, these proteins have been classified into Ras, Rab, Rho, Arf, and Ran families 
[1]. The members of each family can be further subdivided into evolutionarily conserved 
subfamilies, reflecting additional levels of structural, biochemical, and functional 
conservation [1]. All Ras-related GTPases contain five highly conserved domains (G1-
G5) [2]. The activity of Ras proteins is regulated by two major classes of regulatory 
proteins, guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins 
(GAPs) [2]. GEFs can facilitate the release of GDP, promoting the activation of Ras 
GTPases through the binding of GTP. In contrast, GAPs enhance the hydrolysis of GTP 
to GDP, leading to rapid inactivation [2]. The relative proportions of molecules in the 
active and inactive conformation are tightly regulated by GEFs and GAPs. GTP binding 
to Ras proteins triggers a major conformational change, which exposes amino acids in the 
G2 domain (effector domain) so that a variety of intracellular proteins (effector proteins) 
can interact with this domain to initiate an array of signal transduction cascades that 
contribute to almost every aspect of cellular physiology, including cell proliferation, 
differentiation, cytoskeleton reorganization, vesicular and nuclear transport, and most 
recently in the regulation of voltage-dependent calcium channel function [1].  
The RGK (Rem, Rem2, Rad and Gem/Kir) subfamily of small GTP-binding 
proteins is comprised of four members, Rem (also known as Rem1 or Ges), Rem2, Rad, 
and Gem (mouse homolog also referred to as Kir) that share unique structural features 
that distinguish them from the other Ras proteins [3-9]. These include an extended 
variable N-terminal domain with unknown function, several nonconservative 
substitutions within the core domain known to be involved in both GTP/GDP binding and 
hydrolysis in Ras GTPase, an extended and conserved C-terminal domain that directs the 
RGK proteins to the plasma membrane but also serves as a target for intracellular 
 1
regulatory proteins. The fact that RGK proteins differ from one another and other Ras-
related proteins within their putative effector (G2) domains suggests that they likely 
interact with distinct regulatory and effector proteins. Members of the RGK family are 
expressed in a tissue-specific manner. Gem mRNA is expressed in the kidney, lung and 
spleen [5]; Rad mRNA is expressed in both cardiac and skeletal muscle and within the 
lung [6]; Rem mRNA is found in both cardiac and skeletal muscle, lung and kidney [3]; 
whereas Rem2 is the only RGK protein highly expressed within the central nervous 
systems [4]. While classical GEFs and GAPs have not been identified for the RGK 
GTPases (see chapter 1.2), additional approaches to their regulation have been shown, to 
occur at both the transcriptional and posttranscriptional level (see chapter 1.4). Two 
major functions of RGK proteins have been reported. Firstly, RGK proteins have been 
shown to regulate actin cytoskeleton reorganization by interfering with the Rho/Rho 
kinase signaling cascade; Secondly, RGK proteins have been reported to function as 
potent negative regulators of voltage-dependent Ca2+ channel (VDCC) activity by 
interacting with their accessory β-subunits (see chapter 1.6.6). My dissertation focuses on 
addressing the molecular mechanisms underling Rem-mediated L-type Ca2+ channel 
regulation. This is because RGK proteins have been suggested to help maintain normal 
function in a variety of tissues and deregulation of RGK expression has been implicated 
in several different diseases, including heart failure [10], arrhythmias [11] and diabetes 
[6]. In this chapter, the structural and functional properties of the RGK proteins and the 
mechanisms for controlling RGK protein function including phosphorylation, regulatory 
protein binding, and lipid interactions will be discussed. The two major functions of RGK 
proteins will be described and the proposed mechanisms for these regulatory processes 
will be discussed. 
 
1.2 RGK proteins are guanine nucleotide-binding proteins 
The majority of Ras superfamily GTPases display five well conserved (G1 to G5) 
core domains and several amino acids within these regions play critical roles in directing 
both nucleotide binding and GTP hydrolysis [1]. However, RGK proteins contain a 
number of non-conserved amino acid substitutions at multiple positions within these core 
domains [3-9]. For example, RGK GTPases contain substitutions within the G1 motif that 
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is involved in phosphate binding. The residue equivalent to Gly12 in Ras, mutation of 
which results in the constitutive activation of both Ras and Rho family GTPases, is 
altered in all RGK proteins (to Gln in Gem, Ser in Rem2, and Pro in Rad and Rem). 
There are also major substitutions within the G2 and G3 domains, which function to 
sense the gamma phosphate during GTP binding and promote conformational change 
within Ras family proteins during their GTP/GDP activation cycle [3-8]. The highly 
conserved threonine residue within G2 domain (Thr35 in Ras) is substituted by glutamate 
in all of the RGK proteins. The G2 domain is the effector domain functioning as the 
primary downstream effector protein anchoring site and is highly conserved within Ras 
GTPase subfamilies. However, the sequence is highly divergent within this domain 
among the four RGK proteins. This suggests the possibility that different RGK proteins 
either associate with distinct cellular effectors, or perhaps that the RGK effector domain 
involves residues beyond the canonical switch I and switch II regions (see chapter1.3).  
All RGK proteins share a conserved DXWEX G3 motif which diverges significantly 
from the DTAGQ motif found in other Ras family GTPases [12]. Particularly, the 
glutamine residue (Gln61 in H-Ras), which plays a critical role in catalyzing GTP 
hydrolysis, is conserved in Rad and Rem2 but is replaced by alanine in Rem and 
asparagine in Gem. Despite these structural alterations, biochemical studies have revealed 
that all RGK proteins display micromolar affinity for GDP and GTP, which is 
considerably lower when compared with H-Ras. Importantly, all RGK proteins exhibit 
intrinsic GTPase activity [3-9, 13-15]. However, the fact that RGK proteins exhibit 
primary structural alterations when compared with the other Ras superfamily members 
suggests that the mechanism of RGK-mediated GTP hydrolysis maybe unique.   
Because RGK proteins are bona fide GTPases which are capable of alternating 
between a GTP and a GDP-bound state, it is predicted that they will be regulated by the 
actions of both GEF and GAP proteins. While these proteins have not yet been identified 
for RGK GTPases, the in vitro GTP/GDP state of Rad has been found to be modified by 
the tumor suppressor nm23, which can either phosphorylate GDP or dephosphoryate GTP 
while the nucleotide is bound to Rad [16]. Therefore, functionally, nm23 can act as either 
a GEF or a GAP for Rad. It remains to be determined whether nm23 functions as an in 
vivo regulator of Rad, or regulates the actions of other RGK proteins. In addition to 
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nm23, calmodulin was proposed to inhibit GTP binding to Gem [17]. In contrast, a recent 
study also reported that calmodulin binding to Gem C-terminus does not affect the 
kinetics of the nucleotide binding and dissociation, nor does it affect the GTPase activity 
of Gem [8]. Indeed, it remains unclear whether the in vivo nucleotide status of RGK 
proteins is regulated in response to extracellular stimuli, or if GTP-binding is required for 
RGK downstream signaling. Therefore, the identification of RGK regulatory factors and 
RGK downstream targets remains an important goal for the field. Isolation of GEF/GAP 
proteins specific for RGK proteins may assist in the identification of the physiological 
stimuli that control RGK G-protein activation.   
 
1.3 RGK Structure 
The crystal structures of GDP-bound Rad and Gem have been resolved recently 
and it has been demonstrated that the RGK proteins adopt a canonical GDP-binding 
domain (G-domain) fold similar to those found in other Ras family members [7-9]. 
However, because of the amino acid substitutions discussed above, fewer contacts with 
the bound guanine nucleotide are observed [7-9] and in contrast to Ras, whose switch I 
(G2 domain) covers the bound nucleotide, the same domain in Gem folds in a way which  
leaves the nucleotide exposed [7, 8]. Interestingly, a portion of the extended Gem C-
terminus makes contacts with the core G-domain, reminiscent of that seen with the N-
termini of GDP-bound Arf proteins [8, 18] and the C-terminus of Ran [19]. This 
combination of structural alterations likely results in the lower GTP/GDP affinity found 
for RGK proteins when compared to Ras [4, 8]. De Gunzburg and colleagues also 
reported that the GTPase activity of Gem is reduced by removal of the N-terminus, or 
following deletion of both the N- and C-terminal extensions from the conserved GTPase 
core [8]. Together with the structural studies, these biochemical data suggest that 
conformational changes involving rearrangement of the N- and C-termini might play an 
important role in the RGK GTPase cycle, and indicate that the molecular mechanism of 
RGK GTPase activity may be quite different from that of other small GTP-binding 
proteins [8]. Additional crystal structures, particularly of full length RGK proteins in the 
GTP-bound structural state, will be needed to further clarify this potentially novel 
GTPase cycle.  
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The crystal structures combined with in vitro binding studies have recently been 
used to facilitate our understanding of the functional significance in both Gem-CaVβ  [7, 
20] and the Gem-Rho kinase  interactions [7]. Interestingly, mutations of residues in 
distinct regions of Gem were found to disrupt CaVβ association [7, 20]. Mutations of 
residues within the G2 and G3 regions have been shown to be able to inhibit CaVβ 
binding but not affect Gem-Rho kinase mediated neurite outgrowth [7], indicating that 
the CaVβ and Rho kinase binding domains on Gem may be structurally distinct. A recent 
study utilizing molecular modeling in combination with immunoprecipitation analysis 
proposed that residues in the G4-G5 region of all RGK proteins constitute a novel 
effector domain to direct CaVβ binding which is required for their functional regulation of 
voltage-dependent calcium channels activity [20]. Although these data suggest that 
multiple contact sites contribute to these interactions, and appear to involve residues 
outside of the classical G2 effector loop, the functional consequences of these mutations, 
especially those mutations which disrupt CaVβ binding, have not been examined. Thus, 
the picture of how RGK proteins interact with their binding partners has begun to be 
clarified, although resolution of the details of protein association awaits co-crystallization 
studies.  
 
1.4 Regulation of RGK Activity 
The canonical way that the majority of Ras-related GTP-binding proteins are 
activated is by releasing of GDP and binding of GTP with the aid of selective GEFs. 
When their functional consequences have been accomplished, those GTPases will be 
inactivated by hydrolyzing the bound GTP to GDP with the assistance of specific GAPs 
[21]. Since it remains unclear whether RGK protein function is controlled via a classical 
GTP/GDP cycle (see chapter 1.2) and intracellular GEFs or GAPs have not been 
identified, a critical question is how RGK protein functions are regulated? While 
definitive answers await additional study, it appears that both transcriptional and post-
translational control is involved in regulating RGK protein expression. Furthermore, the 
C-terminus has emerged as a key regulatory domain being subject to phosphorylation, as 
well as protein-protein and protein-lipid interactions, to control both the subcellular 
localization and activity of all RGK GTPases. 
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1.4.1  Transcriptional regulation 
 Unlike the other members of Ras GTPase, a unique feature of RGK proteins is 
their ability to be transcriptionally regulated [3, 5, 6, 13, 22-39]. In fact, Gem/Kir was 
discovered as a gene upregulated in human T cells upon stimulation with mitogens [5] or 
in BCR-Abl-transformed B cells [13]. Subsequent studies have found Gem is inducible 
following inflammatory cytokine stimulation in endothelial cells [38] and is responsive to 
muscarinic receptor agonists in neuroblastoma cell lines [28]. Gem has also been shown 
to be upregulated during acute inflammation stimulation in human endothelial cells [39], 
and in the brains of tau-deficient mice [31]. Finally, Gem/Kir expression has been 
correlated with cell invasiveness [40], a key feature of metastatic cancer. Those studies 
pointed out the potential role of Gem in regulating metastatic or inflammatory processes 
upon extracellular stimuli. 
In addition to Gem/Kir, Rad GTPase has also been demonstrated to undergo 
transcriptional regulation in a variety of muscle cell types. Indeed Rad (Ras associated 
with diabetes) was initially identified as a gene overexpressed in the skeletal muscle of 
patients with type II diabetes [6], although subsequent studies in Pima Indians and the 
Zucker diabetic rat model imply that this effect is not universal [41]. Insulin has also been 
shown to enhance Rad mRNA levels in muscle [27], therefore, the upregulation of Rad 
observed in these diabetic conditions may result from the high concentration of insulin 
associated with the disease [42]. In addition, Rad expression is upregulated in both 
developing and post-amputation de-differentiating muscle cells in the newt [35]. A 
similar regulation is also observed in developing and regenerating muscle [22, 26], as 
well as in denervated or injured muscle [22, 29], and in vascular smooth muscle cells 
following balloon injury [23]. While the majority of Rad transcriptional regulation has 
been reported in muscle, other intriguing observations have emerged from other cell 
types. For instance, Rad is upregulated in human peripheral blood mononuclear cells after 
acute heat shock [36] and in human placenta post-hypoxia [24, 33]. Rad expression is 
also correlated with the grade, size, and metastatic potential of breast cancer tumors [37]. 
Less is known concerning the regulation of Rem and Rem2 genes. Rem2 
expression is induced by high concentrations of glucose in a pancreatic β-islet cell line 
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and overexpression of Rem2 prevents glucose-stimulated insulin secretion in pancreatic 
beta-cell lines, presumably by inhibiting L-type Ca2+ channel activity [25]..Similarly, 
Gem/Kir expression is induced in the same cell line in response to elevated glucose, or 
following insulin and KCl treatment [30]. This suggests these RGK proteins could be 
upregulated to function in a negative feedback pathway to prevent Ca2+ overload. Rem2 
is upregulated in developing neurons and the development and maturation of 
glutamatergic and GABAergic synapses is inhibited after the SiRNA-mediated Rem2 
knockdown [32]. Therefore, Rem2 appears crucial for synapse development and 
maturation, which is not too surprising since Rem2 is the only RGK protein abundantly 
expressed in the central nervous system [4]. Finally, Rem expression is increased in 
cardiomyocytes following treatment with isoproterenol, a β-adrenergic receptor agonist 
[34], but decreased in cardiac muscle upon injection of mice with lipopolysaccharide, a 
potent activator of the inflammatory and immune systems [3]. While these results are 
intriguing, the physiological relevance of RGK transcriptional regulation is still unclear. 
However, if RGK proteins are endogenous inhibitors for L-type Ca2+ channels activity in 
native systems, RGK signaling may control a previously unappreciated negative feedback 
cascade operating to protect both pancreatic β-cells (Rem2) and cardiomyocytes (Rem, 
Rad) from uncontrolled Ca2+ signaling in the presence of persistent hyperglycemia or 
chronic β-adrenergic stimulation [25, 34]. Since disruption of intracellular Ca2+ 
homeostasis readily induces cellular dysfunction, these putative pathways may play a 
significant protective role against Ca2+ overloading in normal conditions. Overall, RGK 
GTPases are found to be upregulated in both developmental and disease processes and 
also during adaptive responses to extracellular stimuli. 
 
1.4.2  Post-translational modification   
For RGK proteins, the primary post-translational modification known up to the 
present is phosphorylation. Phosphorylation has been shown to regulate the intracellular 
localization/trafficking of RGK proteins as well as modulate their interactions with 
different binding partners. For example, Rad has been shown to be phosphorylated by 
several kinases, including PKA, PKC, CaMKII, and casein kinase II in vitro [14], and 
these kinases are capable of phosphorylating several distinct serine residues within Rad. 
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Although the physiological relevance of these phosphorylation events is not clear, 
phosphorylation of Rad by PKC and casein kinase II have been shown to disrupt the 
interaction between Rad and calmodulin in vitro [14]. Furthermore, all of RGK proteins 
have been shown to interact with 14-3-3 proteins, a family of regulatory proteins which 
contain conserved domains analogous to the Src homology 2 (SH2) and phospho-tyrosine 
binding (PTB) domains and are capable of binding to serine/threonine-phosphorylated 
residues from a variety of intracellular signaling proteins [43]. RGK/14-3-3 association 
requires RGK proteins to be phosphorylated specifically on N- and C- terminal serines 
[44-48] and this binding appears to provide a unique way to modulate the subcellular 
localization of RGK proteins [44, 46, 47, 49, 50]. For example, RGK proteins are found 
at submembranous/cytoplasmic regions and in the nucleus when overexpressed in COS 
cells, overexpression of 14-3-3 proteins leads to the exclusion of RGK proteins from the 
nucleus [44, 46, 47]. More interestingly, 14-3-3 overexpression can result in efficient 
translocation of camodulin binding null mutants of RGK proteins from the nucleus to the 
cytosol [44, 46, 47]. In addition, phosphorylation of Ser261 and Ser289 in the Gem C-
terminus has been suggested to play a role in Gem-mediated cytoskeletal rearrangements 
[45], although Ser261 phosphorylation is not required for either 14-3-3 or calmodulin 
binding [45]. On the other hand, these same residues phosphorylation do not contribute to 
Gem-mediated inhibition of Ca2+ channel function [45], indicating that the two known 
functions of Gem, and possibly other RGKs, are independently regulated. In summary, as 
the primary post-translational modification, phosphorylation of RGK proteins provides 
efficient ways to regulate the subcellular localization as well as the interactions with 
regulatory proteins; thereby enabling the fulfillment of the functional roles of RGK 
proteins. 
 
1.4.3  Subcellular localization 
Although a large fraction of RGK proteins have been shown to be enriched at the 
plasma membrane, they do not undergo canonical lipid modifications as observed for 
most Ras family members [51]. Individual RGK proteins have been shown to be 
localized to the cytosol, nucleus, and colocalized with both the actin and microtubule 
networks [4, 5, 20, 44, 46, 47, 49-57]. The carboxyl terminus of RGK proteins is well 
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conserved (Figure 1.1) and has been shown to play an important role in directing the 
subcellular distribution [4, 5, 56] and contributing to protein-protein interactions [48, 56, 
58]. More importantly, the conserved C-terminus also plays a crucial role in regulating 
both Ca2+ channel activity [52, 56, 58] and cytoskeletal reorganization [44-47, 49, 50, 55] 
for the RGK proteins. This region contains a cysteine residue within a highly conserved 
domain comprising seven amino acids termed as the C-7 motif (Figure 1.1 and [59]). 
Despite the potential to serve as a site of prenylation, there is no evidence that this 
cysteine residue is modified, and deletion of the C-7 domain does not alter RGK 
localization or function [8, 51, 56, 58]. Therefore, RGK appears to be targeted at the 
plasma membrane through a mechanism other than classical lipid modification. Recent 
work by Heo and colleagues demonstrated that RGK proteins, as well as other Ras-
related GTPases containing multiple polybasic residues in their C-termini, are capable of 
being targeted to the plasma membrane through C-terminal domain interactions with 
phosphatidylinositol phosphate (PIP) lipids [60] (Figure 1.1). Additional studies will be 
necessary to determine whether PIP lipid binding is required for RGK activity and the 
recent studies using Rem and Rem2 C-terminal truncation mutants from our lab did 
suggest a strong correlation between PIP-lipid interaction, plasma membrane localization, 
and Rem/Rem2-dependent Ca2+ channel regulation [56, 61]. In addition to plasma 
membrane targeting through the C-terminus, three specific nuclear localization signals, 
with one localized at the C-terminus and the other two localized within the G-core 
domain have also been reported in all RGK proteins [49, 50]. Recent studies suggest that 
nuclear sequestration may play a role in regulating RGK GTPase function, and appears to 
be controlled in part through interactions with both calmodulin and 14-3-3 proteins (see 
chapter 1.5 and 1.6.6) [44-47, 49, 50].   
 
1.5 RGK regulation of cytoskeletal dynamics: modulation of Rho-
dependent signaling 
        One of the primary physiological roles identified for RGK proteins is the regulation 
of actin cytoskeleton dynamics and cell morphological differentiation. Rho GTPase and 
its downstream effector Rho-Kinase (ROK) have been demonstrated to play a crucial role 
in orchestrating the formation of contractile actin-myosin filaments, which promotes the 
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assembly of stress fibers and focal adhesions in fibroblasts and epithelial cells, or induces 
cell rounding and neurite retraction in neuroblastoma cells [62-65]. Gem overexpression 
has been shown to antagonize Rho kinase induced neurite retraction and cause 
morphological differentiation in N1E-115 and SH-SY5Y neuroblastoma cells [28, 45, 
53]. In epithelial or fibroblastic cells, Gem or Rad overexpression results in stress fiber 
disassembly and focal adhesion dissolution [45, 53]. Consistent with these data, 
overexpression of Rad by either transient or stable transfection in vascular smooth muscle 
cells inhibits the formation of focal adhesions and stress fibers by antagonizing Rho/ROK 
signaling pathway [23]. Gem and Rad have been shown to oppose Rho pathway signaling 
through direct interaction with Rho kinase β or α [53]. Gem has been demonstrated to 
inhibit ROKβ-mediated phosphorylation of myosin light chain (MLC) and the myosin-
binding subunit (MBS) of myosin light chain phosphatase (Figure 1.2) [53], resulting in 
the disruption in the normal assembly of stress fibers and focal adhesions. Furthermore, 
overexpression of Ges, the human orthologue of Rem in several different types of 
endothelial cells has been shown to promote cell sprouting, namely, the morphological 
change from round/oval to elongated or dendritic-like morphology [66] and to inhibit the 
assembly of focal adhesions and stress fibers in human umbilical cord artery endothelial 
cells [66].  
        Intriguingly, a yeast-two hybrid study has identified a novel Gem-interacting protein 
named Gmip [67], which interacts with Gem through its N-terminal half and contains a 
Rho GTPase activating protein (RhoGAP) domain at its C-terminus. Gmip enhances the 
intrinsic GTPses activity of RhoA in vitro and in vivo [67]. Furthermore, the active form 
of Gem was reported to interact with activated Ezrin at the plasma membrane-
cytoskeleton interface [68]. Ezrin association also appears to be required for Gem-
mediated cell elongation and cytoskeleton reorganization and this process appears to 
occur by downregulating the Rho pathway via the participation of RhoGAP Gmip (Figure 
1.2) [68]. Although the exact mechanism underlying the Ezrin-dependent and Gmip-
participated inhibition of Rho GTPase pathway is elusive and remained to be fully 
clarified, this study provided new insight for the existence of a second pathway by which 
RGK regulates Rho-regulated cytoskeleton organization. 
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        The importance of an intact microtubule network, another key component of 
cytoskeleton filaments, has also been shown to be crucial for Gem-mediated cell 
elongation in COS cells [54]. The identification of a novel microtubule-associated 
protein, kinesin-like protein (KIF9), as a Gem-binding partner in a yeast-two hybrid 
screen pointed out the possibility that KIF9 may recruit Gem on microtubules to facilitate 
the interaction between Gem and its downstream effector proteins [54]. Another 
microtubule-associated protein, tau, has been shown to be able to abolish Gem-induced 
elongation of Chinese hamster ovary cells [31], although direct interaction between Gem 
and tau was not observed, Gem GTPase mRNA was significantly upregulated in the 
brains of tau-deficient mice at eight weeks of age, suggesting that tau may play a role in 
Gem-regulated signal transduction pathway [31].  
        Recently, three specific nuclear localization signals (NLS), which are well 
conserved in all RGK proteins, have been shown to contribute to the nuclear localization 
of RGK GTPases through interactions with different importin isoforms [69, 70]. 
Furthermore, two well-known binding partners of RGK proteins, calmodulin and 14-3-3, 
have also been shown to regulate RGK nucleocytoplasmic shuttling and more 
importantly, to mediate cell shape remodeling in fibroblast and skeletal muscle cell lines 
[44, 46, 47, 69, 70]. Overexpression of 14-3-3 has been shown to abrogate RGK-induced 
dendrite-like extensions in COS cells [44, 46, 47] through a yet to be defined mechanism. 
Mutant RGK proteins which do not bind CaM display a predominant nuclear localization 
and lose their ability to induce cell shape changes [44, 46, 47, 69, 70], indicating the 
importance of the subcellular localization in RGK-mediated cytoskeleton reorganization. 
Moreover, phosphorylation of a couple of serine residues in Gem C-terminus is required 
to maintain cytoplasmic localization [69], which may explain why phosphorylation of 
these residues is required for Gem-mediated cytoskeleton reorganization [45]. Therefore, 
nucleocytoplasmic shuttling of RGK proteins may represent an important modulatory 
mechanism in mediating RGK-dependent cell shape remodeling and cytoskeleton 
reorganization, and this process seems to be dynamically regulated by ubiquitously 
expressed intracellular proteins and the phosphorylation status of the RGK C-terminus. 
Whether and how these dynamic processes are correlated with Rho GTPase-mediated 
cytoskeleton reorganization remains to be clarified.     
 11
        In summary, RGK proteins may mediate cytoskeleton reorganization and cell shape 
remodeling by regulating Rho-dependent pathways through two different mechanisms. 
Figure 1.2 depicts the proposed mechanisms for Gem. In the first, Gem antagonizes Rho-
mediated cytoskeleton reorganization through direct association with ROKβ, thereby, 
inhibiting the phosphorylation of myosin light chain and myosin phosphatase and 
abolishing the formation of myosin–actin filaments [53]. In the second, GTP-bound RGK 
proteins interact with the membrane-cytoskeleton linker protein Ezrin in its active state 
and direct the Rho-GAP protein Gmip to the plasma membrane. Recruitment of Gmip 
down-regulates Rho pathway signaling; inhibiting the formation of stress fibers and focal 
adhesions [67, 68]. These two mechanisms could act synergistically or independently to 
down-regulate activities of Rho pathways.  
   
1.6 RGK inhibition of voltage-dependent Ca2+ channels 
 The other major function of RGK proteins is to regulate voltage-dependent Ca2+ 
channel (VDCCs) activity. Since this dissertation is focused on addressing the molecular 
mechanisms underling this regulation, I will first provide background information for the 
VDCCs, including their structure, functions, classification, and regulation by kinases 
pathways. The proposed mechanisms for RGK-mediated VDCC regulation will be then 
discussed in detail.  
 
1.6.1 Introduction of VDCCs  
        VDCC plays a central role in mediating Ca2+ entry into electrically excitably cells 
and it modulates a wide variety of cellular functions including excitation-contraction 
coupling in cardiac muscle cells, neurotransmitter releasing and dendritic Ca2+ transients 
in neurons, hormone secretion in endocrine cells, and gene expression in many different 
cell types (Figure 1.3) [71]. VDCC opens in response to membrane depolarization, a 
change in the membrane potential toward the less negative value [71]. Based on their 
specific physiological and pharmacological properties, five types of VDCCs have been 
identified, including L-, P/Q-, N-, R-, and T-type (Figure 1.3). L-type currents are “long 
lasting” currents when Ba2+ is used as the charge carrier [72] and they are activated at 
relatively high voltage and characterized by large single channel conductance, slow 
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voltage-dependent inactivation, and specific inhibition by drugs including 
dihydropyridines, phenylalkylamines and benzothiazepines [73]. In contrast, T-type 
currents are “transient” currents which activate at much more negative membrane 
potentials, inactivate very rapidly, have small single-channel conductance and are 
insensitive to Ca2+ antagonist drugs [72]. N-type Ca2+ currents are characterized by their 
intermediate voltage-dependence and rate of inactivation in comparison with L-type and 
T-type Ca2+ channels [72]. N-type Ca2+ channels are insensitive to L-type Ca2+ channel 
blockers but are blocked by the cone snail peptide ω-conotoxin GVIA [74, 75]. In 
addition, P/Q type Ca2+ currents are distinguished by their sensitivity to the spider toxin 
ω–agatoxin IVA [76, 77]. L-type and T-type Ca2+ channels are expressed in a wide 
variety of cell types, however, P/Q-, N- and R-type Ca2+ channels are predominantly 
expressed in neurons [71]. VDCCs have also been classified, according to the voltage 
dependence of activation, into high voltage activated (HVA) channels, including L-, P/Q-
, N-, R-type (Figure 1.3) and low voltage activated (LVA) channels, including T-type 
channel (Figure 1.3). T-type channel may play important roles in cardiac pacemaker 
activity and the oscillatory activity of some thalamic neurons [71].  
 
1.6.2 Structure of VDCCs 
        VDCCs minimally consist of a pore-forming α1 subunit, an intracellular β subunit, 
and a transmembrane complex α2/δ subunit [71] (Figure 1.4). Ca2+ channels purified 
from the transverse tubule membranes of skeletal muscle also contain a γ subunit [78]. 
The α1 subunit is a protein of 190-250 kDa [79] and possesses gating function. The α1 
subunit has four homologous domains, each composed of six transmembrane helices 
connected by variable intracellular loops, and cytoplasmic domains containing the amino 
(N) and carboxyl (C) termini (Figure 1.4). The four α1 domains cluster in the membrane 
to form the ion pore and the voltage sensor for the channel, which is primarily formed by 
positively charged lysine and arginine residues in the S4 helix of the four homologous 
domains. Upon membrane depolarization, S4 segments move outward and rotate in 
response to the electric field and this movement triggers a conformational change that 
enables the opening of the pore [71]. A membrane associated loop between 
transmembrane segments S5 and S6 which lines the pore of the channel, contributes to 
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the ion selectivity of the channel [80, 81]. To date, ten different α1 subunit genes have 
been cloned, which provide unique functional properties to Ca2+ channels found in 
different cell types [71]. Differences in the nature of the α1 subunits largely determine the 
different types of Ca2+ currents. Those subunits are divided into three related families 
(Cav1, Cav2, and Cav3) based on their structural and functional similarities [82]. The Cav1 
family of α1 subunits conducts the L-type Ca2+ current. Cav2.1, Cav2.2, and Cav2.3 
subunits mediate the P/Q-type, N-type, and R-type of Ca2+ current, respectively. T-type 
Ca2+ currents are conducted by Cav3 channels (Figure 1.3). The accessory β subunit is 
localized intracellularly and plays an important role in enhancing peak current amplitude 
for the L-type, P/Q-type, N-type, and R-type channels, increasing the number of channels 
at the cell surface and regulating channel gating properties [83]. A conserved α1 
interaction domain (AID) located between the first and second repeats of the Cavα1 
subunit, serves as a high affinity binding site for all Cavβ’s (Figure 1.4). AID:β 
association promotes trafficking of the channel complex to the plasma membrane and 
results in increased current density [84]. Four different β subunits (β1-β4) have been 
identified and they have distinct effects on voltage-dependent and kinetic properties of 
channel activation [83]. The α2 subunit is a highly glycosylated extracellular protein that 
is attached to the membrane spanning δ subunit by means of disulfide bonds [85, 86]. γ 
Subunit is a glycoprotein having four transmembrane segments [87]. So far, four α2/δ 
complexes and two γ subunits have been identified. Although coexpression of α2/δ or γ 
subunit increases the peak amplitude and affects the activation or inactivation kinetics of 
channel complexes [88], they have much smaller functional effects compared with the 
effects derived from the coexpression of β subunits [89, 90].  
        Different types of Ca2+ channels are regulated through distinct intracellular signaling 
pathways. Cav1 family of Ca2+ channels are regulated primarily by protein 
phosphorylation through second messenger activated kinase pathways [71]. Cav2 family 
of Ca2+ channels are regulated primarily by direct association with G proteins, and 
SNARE proteins and are also regulated by protein phosphorylation [71]. The regulation 
of Cav3 Ca2+ channels is not well understood. Because this dissertation is focused on 
understanding RGK-mediated cardiac Cav1.2 channel regulation, only regulation of 
Cav1.2 cardiac Ca2+ channels will be discussed further. 
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1.6.3 Regulation of Cav1.2 cardiac Ca2+ channels by protein kinase A and C 
        Ca2+ influx mediated by Cav1.2 L-type Ca2+ channels plays a crucial role in cardiac 
excitation-contraction coupling, which is the process that links electrical excitation of the 
cardiomyocytes to contraction of the heart [91]. The activation of the L-type Ca2+ 
channels contributes to the plateau phase of the cardiac action potential. A variety of 
cardiovascular diseases, including atrial fibrillation [92, 93], heart failure [94-96] and 
ischemic heart disease [97] have been correlated with alterations in the density or 
function of L-type Ca2+ channels. In cardiomyocytes, L-type Ca2+ channels are located 
primarily at sarcolemmal-sarcoplasmic reticulum (SR) junctions which are in close 
proximity to the Ca2+ release channels (or ryanodine receptors; RyRs) [98]. When L-type 
Ca2+ channel opens, Ca2+ influx triggers the release of intracellular stores of the Ca2+ 
from the SR, the combination of Ca2+ influx and efflux from intracellular stores leads to 
the rapid increase of the free intracellular Ca2+ concentration, enabling Ca2+ to bind to the 
myofilament protein troponin C, which results in the activation of the myofilaments and 
the ensuing heart contraction [91]. Cardiac L-type Ca2+ channels are regulated by a 
variety of neurotransmitters, hormones, and cytokines. β-Adrenergic modulation in 
cardiac muscle is the most thoroughly studied and a well-established model of regulation. 
β-Adrenergic stimulation remarkably enhances Ca2+ current and contributes to the 
increased cardiac contractility, heart rate, and amplitude of the cardiac action potentials 
[99, 100]. β-Adrenergic receptors are members of the heterotrimeric G protein-coupled 
receptors (GPCRs). β-Adrenergic receptor stimulation activates a GTP-binding protein 
Gs, which stimulates adenylyl cyclase (AC). An increase in AC activity leads to increased 
intracellular cAMP, which in turn binds to the regulatory subunits of cAMP-dependent 
protein kinase (PKA). Full length Cav1.2 subunit is phosphorylated on a single serine 
residue (ser1928) in the distal C-terminus by PKA [101]. Because mutation of this serine 
residue to alanine abolishes PKA-mediated regulation of Ca2+ channel activity [102], it 
has been proposed that ser1928 phosphorylation at least partially contributes to the PKA-
dependent activation of Ca2+ channel activity.     
        cAMP-dependent protein kinases are usually found to be anchored to specific 
subcellular compartments where they are in close proximity to their specific kinase 
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substrates by A kinase anchoring proteins (AKAPs) [103, 104]. These proteins consist of 
a targeting domain that associates with the regulatory subunit of cAMP-dependent 
protein kinase. AKAPs were thought to be an ideal candidate to bring PKA to close 
proximity to Ca2+ channel because the regulation of skeletal muscle Ca2+ channel by PKA 
occurs in a timescale of 50 ms [71]. Immunoprecipitation studies identified a novel 15 
KD AKAP (AKAP-15) associated with skeletal muscle L-type calcium channels [105]. 
Consistent with this finding, a peptide containing the amino acid sequence of an AKAP 
anchoring domain effectively inhibits rapid, voltage-dependent enhancement of skeletal 
muscle Ca2+ channel activity in cultured skeletal muscle cells [106] or in HEK cells 
expressing those channels [107]. AKAP-15 is expressed in the heart [108, 109] and it 
colocalizes with Cav1.2 channels and PKA in the transverse tubules of isolated 
ventricular myocytes [110]. It has also been shown that AKAP-15 directly interacts with 
the distal C-terminus of the cardiac L-type channels and that this interaction is required 
for β-adrenergic regulation of Cav1.2 channels via the PKA signaling pathway in 
ventricular myocytes [110]. Single channel studies have been used to elucidate the 
mechanism of regulation of cardiac Ca2+ current by cAMP-dependent protein kinase. 
While conflicting data have been generated in terms of changes in the number of 
functional channels recorded in response to the β-adrenergic agents in rat or frog 
myocytes [111-113], β-adrenergic stimulation is proposed to increase the channel 
opening probability by shifting the channel gating mode from the null gating mode P0, in 
which channels do not open or open very rarely upon depolarization to the P1 and P2 
modes, which are characterized by low opening probability and brief opening or much 
higher opening probability and longer opening, respectively [71]. While the 
phosphorylation of Cav1.2 C-terminus at position 1928 appears essential for the β-
adrenergic modulation of the Ca2+ current in cardiac muscle, β-subunits of cardiac Ca2+ 
channels have also been reported to be phosphorylated by PKA in intact hearts treated 
with β-adrenergic agonists [114] and the phosphorylation of ser478 and/or ser479 of β2a 
subunit has been proposed to play a role in regulation of cardiac Ca2+ channels activity 
[115].   
        PKC also plays an important role in the regulation of cardiac L-type Ca2+ channels. 
Multiple Gq protein-coupled receptors, such as endothelin, α1-adrenergic, and angiotensin 
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II receptors initiate the signaling pathways resulting to the activation of PKC [116]. 
Activation of PKC in cardiomyocytes has been shown to produce complicated effects on 
Ca2+ current and heart contractility. A transient increase followed by a sustained decrease 
in Ca2+ current has been reported upon PKC activation [117-119]. Different responses 
between Cav1.2 channels cloned from heart and brain upon PKC activation have been 
observed, which has led to the hypothesis that structural differences in the N-termini of 
these channels may contribute to these distinct regulatory consequences. Additional 
mutagenesis studies have indicated that threonine 27 and threonine 31 of the cardiac 
isoform must be phosphorylated by PKC to inhibit Ca2+ channel activity [120]. 
Conflicting results have also been reported in studies focused on understanding the 
modulation of Ca2+ current by PKC. The distinct effects may be due to differences in 
experimental conditions, species, PKC isoforms, and methods used to study Ca2+ channel 
modulation [121]. Clearly, the effect of PKC activation on cardiac Ca2+ channels 
modulation awaits further investigation.  
 
1.6.4 Ca2+ channel self-regulation: voltage-dependent inactivation (VDI) and 
calcium-dependent inactivation (CDI) 
As a key mediator of Ca2+ influx into cardiac myocytes, the opening and closing of 
VDCCs need to be tightly regulated. In cardiomyocytes, several pumps and exchange 
proteins function together to remove Ca2+ ions from the cytoplasm to restore the basal 
level of Ca2+ concentration needed before relaxation of cardiac muscle can occur. These 
transporters and exchange proteins include SR Ca2+-ATPase, sarcolemmal Na+/Ca2+ 
exchanger, sarcolemmal Ca2+-ATPase and the mitochondrial Ca2+ uniporter [91]. In 
addition to these pathways, two distinct mechanisms named after their primary trigger, 
either voltage- or Ca2+-dependent inactivation, also play essential roles in fine-tuning the 
intracellular Ca2+ levels to prevent toxic Ca2+ overload. Membrane depolarization not 
only triggers the opening of Ca2+ channels, but also promotes the closure of these 
channels, with voltage-dependent inactivation (VDI) being the process of channel 
inactivation generated by membrane depolarization. Ca2+-dependent inactivation (CDI) is 
characterized by the ability of entering Ca2+ to accelerate channel closing during a 
sustained depolarization.  
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As described above, inactivation of Cav1.2 channels is mediated by both voltage and 
Ca2+ [122]. VDI can be recorded by using extracellular Ba2+, a cation that can not bind 
calmodulin. Thus, CDI can be experimentally separated from VDI simply by replacing 
Ba2+ by Ca2+ [123]. L-type CDI is characterized by a decrease in the mean channel 
opening time during sustained depolarization when Ca2+ is used as the charge carrier and 
single channel recordings indicated that the Ca2+ influx through a single channel is 
sufficient to induce CDI [124].  
        Due to the observations that strong Ca2+ chelators such as BAPTA fail to inhibit 
CDI of L-type Ca2+ channels [125], the Ca2+ sensor for CDI is assumed to be located 
close to the inner mouth of the channels. The proximal portion of the C-terminal tail of 
Cav1.2 channels contains a short sequence which is homologous to a Ca2+-binding EF 
hands. This EF hand motif was originally thought to be the Ca2+-binding site and this 
binding process was thought to trigger CDI [126]. However, subsequent studies indicated 
that this EF-hand is not an operational Ca2+-binding site [127] and instead calmodulin 
was acknowledged to be the main Ca2+-sensor mediating CDI [128, 129]. Calmodulin 
(CaM) is a ubiquitously expressed Ca2+ binding protein that is comprised of four FE-hand 
motifs. The two lobes at the C-terminus of CaM exhibit high affinity for Ca2+ (Kd 
approximately 0.1 μM) and the other two lobes at the N-terminus show relatively low 
affinity for Ca2+ (Kd approximately 1 μM) [130]. One important question concerning 
Ca2+/CaM-mediated Ca2+ channel inactivation is how CaM may be tethered to the Ca2+ 
channels. There are a couple of lines of evidence indicating that CaM is constitutively 
tethered to the channel complex, even before any Ca2+ influx occurs. First, CaM tethering 
can explain how the development of CDI occurs within milliseconds after the opening of 
L-type Ca2+ channels [131]. Secondly, it can help explain the observation that 
overexpression of a Ca2+ insensitive CaM mutant (CaM1234, a mutant that fails to bind 
calcium to any lobe) disrupts CDI in a “dominant-negative manner”. It is hypothesized 
that binding of the mutant to the tethering site precludes binding of wild type CaM [128, 
129, 132]. The finding that a Ca2+-insensitive CaM mutant which is unable to bind Ca2+ 
at three of its four EF hands also functions as a dominant-negative to block CDI suggests 
that Ca2+ -free CaM (ApoCaM) can bind to L-type Ca2+ channels [129]. Furthermore, 
CaM with Ca2+ bound at only one of the lobes can also bind to VDCCs and regulate their 
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function [133-136]. In fact, CDI of Cav1.2 channels depends on Ca2+-binding to the C-
lobe of CaM [137]. The ability of channels to bind multiple forms of CaM in which Ca2+ 
binds different lobes of the protein increases the flexibility of channel regulation in 
response to different channel functional states [138]. An important unanswered question 
is the exact location of the docking site(s) of ApoCaM or Ca2+/CaM on Cav1.2 channels. 
It has been established that the C-terminal tail of the Cavα1 subunit is the primary docking 
site for CaM [128, 129]. In the proximal Cav1.2 C-terminus, three conserved regions 
designated as A, CB, and IQ domains, all have been implicated in ApoCaM binding, 
although the exact amino acids involved in ApoCaM binding remains controversial [138]. 
Pitt et al. [137] proposed that ApoCaM is anchored close to the A and CB motifs in 
Cav1.2 channels. While this finding was been supported by additional studies [139], 
Erickson et al. [140] also reported that mutations in the IQ region abolished ApoCaM 
binding using fluorescence resonance energy transfer methods, suggesting that the IQ 
motif may also play a role in ApoCaM binding. Furthermore, Tang et al. [141] reported 
an  interaction between ApoCaM and a synthetic IQ peptide. Moreover, A, CB and IQ 
motifs have all been implicated in the tethering of Ca2+-CaM [137, 142-144]. Although 
the exact binding sites for ApoCaM and Ca2+-CaM on the Cav1.2 C-terminus is 
controversial, and appear to dependent in part on the functional status of the channel 
[138], there is general agreement that Ca2+ binding to CaM elicits a major conformational 
change in the Cav1.2 C-terminus which initiates CDI [139, 145]. In one of these models, 
at resting Ca2+ levels, CaM is proposed to occupy sequences A and CB, with its N-lobe 
associated with domain A, whereas peptide CB is localized between the N- and C-lobes 
of CaM. Upon membrane depolarization Ca2+ ions flux into the cell and bind to the C-
lobe of CaM which enables a direct interaction between the IQ domain of the α1 subunit 
and the C-lobe of CaM. This process is proposed to trigger the development of CDI and 
rapid channel inactivation [137]. A recent study by Pitt and colleagues suggests that Ca2+ 
-bound CaM elicits a conformational change within the Cav1.2 C-terminus which 
promotes its binding to the α1C I-II intracellular linker, resulting in channel inactivation 
[145]. Indeed, mutation of an isoleucine resdiue to a glutamate within the IQ domain (IQ 
to EQ) dramatically disrupts CaM binding and abolishes CDI [129]. Mutations of other 
residues in the IQ domain which disrupt IQ:CaM association also prevents CDI [131]. It 
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has also been proposed that both CDI and Ca2+ signal transduction depend on the 
mobility of the Cavα1 C-tail [139]. In this model, ApoCaM binds to a preIQ domain in 
resting channels, and upon channel opening, a Ca2+-dependent switch of CaM from the 
preIQ domain to the IQ domain removes CaM from the inner mouth of the pore and thus 
facilitates the constriction of the pore by promoting the movement of S6 segments toward 
the pore [139]. 
        CaM has also been shown to interact with N-terminus of L-type Ca2+ channels in a 
Ca2+-dependent manner [125, 146] and this association has also been shown to contribute 
to the generation of CDI [125]. Although it has not been well established, Ca2+/CaM has 
been proposed to bridge N- and C-terminus of L-type Ca2+ channels to induce CDI [125].   
        Ca2+/CaM-mediated CDI represents an essential auto-regulatory process in L-type 
Ca2+ channel activity and this regulation requires participation of the C-terminus of Cavα1 
subunit, which has been shown to play a role in Rem-mediated L-type Ca2+ channel 
regulation [57]. Since my project focuses on addressing the interaction between Rem and 
the C-terminus of Cav1.2 subunit and its role in Rem-mediated channel regulation, an 
important question is whether Ca2+/CaM competes with Rem for Cav1.2 C-terminus 
binding and whether Rem:Cav1.2 C-terminus association alters the kinetics of CDI. 
Those questions will be addressed in chapter 4.   
 
1.6.5 Other important functions of the Cav1.2 C-terminus 
        In addition to its well-established role in CDI, the IQ domain also plays an important 
role in Ca2+-dependent facilitation (CDF) [129], a process by which increased basal Ca2+ 
or repeated transient depolarization results in enhanced channel opening [147]. In 
addition, Ca2+/Calmodulin-dependent protein kinase II (CaMKII), a multifunctional 
Ser/Thr protein kinase, has been demonstrated to bind to Cav1.2 C-terminus in a region 
that includes the CB/IQ domain to support CDF during repetitive depolarization [148]. 
The distal Cav1.2 C-terminus also contains inhibitory elements [149-151]. Removal of up 
to 70% of the C-terminus has been reported to increase current density by enhancing 
opening probability of the channel [151]. Interestingly, a recent study has demonstrated 
that the Cav1.2 C-terminal fragment which contains residues after CB/IQ domain to the 
end of C-tail can regulate gene transcription by translocating to the nucleus [152]. This 
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provides the first evidence that the Cav1.2 C-terminus has a dual function contributing to 
channel regulation and as a transcription factor.     
 
1.6.6 Regulation of VDCCs function by RGK proteins  
 In 2001, Beguin and colleagues first identified an interaction between the Gem 
GTPase and the β subunit of the VDCCs in a yeast two-hybrid study and they also 
reported that overexpression of Gem potently inhibits high-voltage-activated calcium 
channels activity [55]. In the same study, they proposed that Gem interferes with CaVα1 
trafficking to the plasma membrane by sequestrating CaVβ from CaVα1 [55] (Figure 
1.5A), which is required for the formation of the functional channel complex at the cell 
surface [153]. Thus, Gem-mediated CaVβ sequestration would lead to decreased channel 
activity upon overexpression due to the retention of the newly synthesized CaVα1 subunits 
in an intracellular compartment [55]. Recently, all members of the RGK family have 
been shown to dramatically inhibit high-voltage-activated calcium channel activity upon 
overexpression either in endogenous or heterologous expression systems, including L- 
[11, 25, 55-58, 154-156], P/Q- [55], and N- [52, 55], but importantly not T-type channels 
which do not require accessory β-subunits for ionic current expression [58, 71]. 
Furthermore, overexpression of RGK proteins has been shown to inhibit Ca2+-dependent 
exocytosis by affecting the activity of L-type VDCCs. Examples include inhibition of 
transfected human growth hormone secretion in PC12 and C-peptide secretion in MIN6 
cells by Gem [55, 157] , and inhibition of insulin secretion in Min6 cells by Rem2 [25]. 
Recent studies in Xenopus oocytes demonstrated that the extent of calcium channel 
inhibition may depend on the amount of RGK expressed in a specific cell [156]. While 
CaVβ binding has been acknowledged as an important component for RGK-mediated 
calcium channel regulation [55, 57, 58, 155, 156, 158], the mechanism(s) underling 
RGK-mediated channel regulation remain poorly understood. Subsequent work using 
immunofluorescence analysis demonstrated that Rad, Rem and Rem2 can all inhibit the 
trafficking of epitope-taged CaVα1 to the cell surface [20, 44, 46]. As two common 
binding partners for RGK proteins, the importance of CaM or 14-3-3 binding in RGK-
mediated calcium channel regulation has also been examined. The fact that RGK mutants 
which fail to bind 14-3-3 are still capable of inhibiting calcium channel function [44, 46, 
 21
47], indicates that 14-3-3 binding is not required for RGK-mediated channel inhibition. 
However, CaM binding appears critical for Gem and Rad [44, 47], but not for Rem and 
Rem2-mediated channel inhibition [44, 46, 159]. While the reason for this discrepancy 
are not clear, Beguin and colleagues reported that Rem and Rad mutants  deficient for 
CaM  binding predominantly localized in the nucleus along with their associated CaVβ 
subunit, suggesting that RGK:CaVβ sequestration within the nucleus might provide a 
second mode for regulating α1 trafficking [44, 46, 47, 49, 50].  
The effect of RGK overexpression on channel gating current amplitude has also 
been investigated. Gating current for L-type Ca2+ channels is induced by the movement 
of the voltage sensors located in the S4 segments of the four homologous transmembrane 
domains of Cavα1 subunit prior to the channel opening. It provides a way to measure the 
number of functional channels with movable voltage sensors in the plasma membrane 
[71]. Adenovirus-mediated Gem overexpression in guinea pig ventricular cardiomyocytes 
leads to reduced gating currents, which is consistent with a loss of functional channel 
complexes at the plasma membrane and supports the trafficking mechanism of RGK 
function [160]. Rem overexpression has also been shown to inhibit skeletal muscle EC 
coupling and reduce skeletal muscle charge movement, suggesting decreased number of 
“functional” L-type Ca2+ channels in the plasma membrane after Rem overexpression 
[161]. However, those studies could not determine whether this was  caused by a 
decrease in channel number at the plasma membrane or if RGK proteins were capable of 
locking channel complexes in a nongating state [161]. In contrast to the reported 
reduction in gating current in ventricular myocytes or skeletal muscle cells upon 
overexpression of RGK proteins, a recent study using heterologous expressed L-type 
Ca2+ channels in HEK293 cells also indicated that acute translocation of Rem from the 
cytosol to the plasma membrane can inhibit L-type Ca2+ current amplitude rapidly 
without reducing gating charge movement [162]. Moreover, the ability of RGK 
expression to alter Ca2+ channel trafficking to date has only been directly demonstrated 
for L-type channels in heterologous expression systems [20, 44, 46, 47, 55]. Indeed, 
studies using endogenously expressed channels suggest that inhibition of CaVα1 
trafficking is not the primary reason for the dramatic decrease in Ca2+ ionic current. For 
example, using surface-biotinylation analysis, our laboratory has reported that cell 
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surface expressed CaVα1 subunit is not reduced in pancreatic β cells by Rem or Rem2 
overexpression at a time when both GTPases result in a complete block of Ca2+ channel 
activity [25, 155]. Using another approach, similar finding was reported for Rem2-
mediated N-type calcium channels stably expressed in tsA201 cells [52]. In the same 
paper, it was demonstrated that blocking protein translation in neurons by cyclohexamide 
for 20-29 hours did not generate the channel inhibition seen following RGK expression.  
Since overexpression of RGK proteins can dramatically and rapidly inhibit Ca2+ current  
and RGK proteins have been proposed to interfere with the synthesis of new Ca2+ 
channels [163], this study argues that turnover of endogenous preformed channel 
complexes is not quick enough to generate Ca2+ current block seen in  these experiments. 
In addition, these studies suggest that RGK proteins are generating acute channel 
blockade by promoting a nonconducting complex with channel subunits at the cell 
surface [52].  
        In the trafficking model, an important property for RGK proteins is their ability to 
disrupt CaVα:CaVβ association [55, 157]. All CaVβ subunits contain well conserved SH3-
like and GK-like domains which are connected by three other variable regions [84]. The 
primary interaction between CaVα:CaVβ involves the participation of the GK domain 
found within all CaVβ subunits and a conserved domain named the AID domain located 
in the I-II loop of CaVα1 subunit [84, 164, 165]. Deletion mapping studies have located 
the Rem [155] and Rem2 [61] binding domain to a region within the GK domain of CaVβ 
subunits. However, CaVβ mutants were identified which had lost the ability to bind CaVα 
but retained the ability to bind Rem, suggesting that the AID and Rem association sites 
on CaVβ are structurally distinct [155]. More importantly, RGK proteins can not inhibit 
the association of CaVβ with AID using both in vitro and in vivo association assays [61, 
155], which is perhaps not surprising when you consider that the affinity of RGK proteins 
for CaVβ is much lower than the affinity of CaVβ for AID domain [155]. As a matter of 
fact, recent studies suggest that CaVβ plays a scaffolding role, simultaneously associating 
with RGK and CaVα1 to form a trimeric RGK-CaVβ-CaVα1 regulatory complex [20, 155]. 
Formation of this complex might inhibit channel function at the plasma membrane, 
without disrupting CaVα1-CaVβ association or inhibiting CaVα1 expression at the plasma 
membrane (Figure 1.5B). However, it is also possible that a similar RGK-CaVβ-CaVα1 
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regulatory complex might form in the endoplasmic reticulum and sequester CaVα1 in this 
organelle, serving to reconcile the apparent contradictions in the two regulatory models 
(Figure 1.5A).   
Since RGK proteins are bona fide GTPases, an important question is whether 
VDCC regulation is a GTP-dependent process. It has been reported that in vitro CaVβ 
binding requires GTP-bound Gem [55], however, studies from our lab indicate that the in 
vitro CaVβ:Rem or CaVβ:Rem2 association does not depend upon the nucleotide-binding 
status of Rem [155] or Rem2 [61]. More importantly, channel regulation has been 
reported to be nucleotide-independent for Rem2 [52], but GTP binding appears to be 
crucial for Rad-mediated channel inhibition [11]. It is possible that different RGK 
proteins use different molecular mechanisms to inhibit Ca2+ channel function. Therefore, 
the importance of nucleotide binding in individual RGK proteins-mediated channel 
modulation awaits further investigations [163].   
         While the effects of RGK overexpression are well characterized, the physiological 
effects of these proteins on calcium channel activity at endogenous levels in native 
systems remains poorly characterized. Recent studies using transgenic mice have started 
to reveal the physiological roles of RGK proteins. Transgenic mice overexpressing Rad 
specifically in skeletal muscle have been shown to be more susceptible to the 
development of insulin resistance and glucose intolerance induced by high-fat diet and 
exhibit lower plasma triglyceride levels than wild-type littermates [166]. Rad knockout 
mice have also been generated and found to be more susceptible to cardiac hypertrophy 
and to display increased CaMKII activity when compared to wild-type littermates [10]. 
More interestingly, the same study also reported that levels of Rad mRNA and protein 
were decreased significantly in human failing hearts compared with normal hearts [10] 
and Rad expression was decreased significantly in cardiac hypertrophy, suggesting Rad 
plays an important role in maintaining normal cardiac function. However, whether 
endogenous L-type calcium channel function is altered in the cardiomyocytes from Rad 
knockout animals was not investigated. To that end, Yada and colleagues has generated 
transgenic mice which overexpress a mutant form of Rad (RadS105N) [11].  S105 in Rad 
corresponds to the S17 in H-Ras and overexpression of H-RasS17N enables the 
sequestration of GEFs available in the cell and disrupts the GTP-loading and activation of 
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endogenous H-Ras [167]. Although biochemical analysis has yet to be performed for 
RadS105N, this mutation is postulated to function in a dominant-negative manner by 
inhibiting the activity of both endogenous Rad, and perhaps all RGK GTPases by 
sequestering putative RGK GEFs [167]. This mutant was found incapable of binding  
CaVβ subunits or inhibiting L-type calcium channel activity [11]. Adenovirus-mediated 
transduction of the mutant into primary cardiomyoctytes resulted in both increased 
current density and prolonged action potential [11], suggesting that RadS105N may 
interfere with the normal functioning of wild-type RGK proteins and thus modulate Ca2+ 
channel activity. ECG recordings from transgenic mice overexpressing RadS105N 
demonstrated a longer QT interval and showed an increased propensity for arrhythmia 
under both resting and stimulated conditions [11]. To date, this study provides the most 
compelling evidence to suggest that RGK proteins are endogenous regulators of VDCCs. 
Recently, Murata and colleagues used gene therapy to deliver the Gem GTPase into 
porcine heart and showed that it was effective in the reduction of heart rate during atrial 
fibrillation, a frequently encountered sustained arrhythmia [160]. Thus, manipulation of 
RGK activity might provide a novel therapeutic approach to the treatment of 
cardiovascular disease. 
        Lastly, recent studies also indicated that the conserved C-terminus of RGK proteins 
plays important role in regulating VDCCs function [52, 56, 58, 162], primarily by 
directing RGK proteins to the plasma membrane (Figure 1.5B). Truncation of the Rem or 
Rem2 C-terminus disrupts plasma membrane localization and abolishes VDCC 
regulation, but interestingly, does not eliminate CaVβ binding [52, 56, 162]. This has led 
to the suggestion that CaVβ binding alone is not sufficient to generate channel inhibition. 
However, addition of the  C-terminal membrane anchoring domains from K-Ras4B or H-
Ras to the C-terminus of Rem [56, 162] or Rem2 [52] truncation mutants allows for the 
recovery of calcium channel inhibition; presumably by restoring the plasma localization, 
indicating that the plasma membrane localization is essential for RGK-mediated calcium 
channel regulation. This suggests that RGK proteins are likely forming a complex with 
the membrane-localized Ca2+ channel subunits to inhibit channel function. Therefore, in 
addition to CaVβ binding, the plasma membrane localization of RGK proteins appears to 
be another essential determinant in the generation of channel inhibition. Therefore, the 
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ability of RGK proteins to modulate Ca2+ channel function may be regulated by altering 
their subcellular localizations. In fact, the subcellular localization of RGK proteins has 
shown to be regulated by post-translational modifications or interactions with a variety of 
binding partners through the RGK C-terminus, including PIP lipids [56, 60, 61], 
calmodulin [44, 46, 47, 49, 50] or 14-3-3 [44, 46, 47, 49, 50], etc. For instance, RGK C-
terminus has been shown to undergo a series of complex 
phosphorylation/dephosphorylation regulation [14, 44-48], which alters the subcellular 
localization of these proteins. Furthermore, the RGK C-terminus may target those 
proteins to the plasma membrane by interacting with the negatively charged PIP lipids 
[56, 60, 61] (Figure 1.5B), and this interaction may be subject to regulation. Indeed, 14-3-
3 bound Rem2 loses its ability to bind PIP lipids, and Rem2:PIP binding can be recovered 
by disrupting Rem2:14-3-3 association [61]; thus, 14-3-3 binding is likely able to 
sequester Rem2 protein from plasma membrane association and this whole process can 
be reversibly regulated by phosphorylating or dephosphorylating a pair of serine residues 
located at the N- and C- termini of Rem2 [46]. Therefore, RGK:14-3-3 binding may 
provide a potential mechanism for regulating RGK localization and thereby modulating 
channel function [61].    
In summary, RGK proteins function as important regulators for cytoskeletal 
reorganization and VDCC function. Regulation of actin dynamics is achieved through 
interference of Rho/ROK signaling pathways. Regulation of the VDCC function appears 
to involve association with CaVβ subunits and the plasma membrane localization of the 
RGK proteins. Although RGK proteins have been shown to inhibit Ca2+ channel function 
by forming a complex with channel subunits at the plasma membrane, little is known 
about the molecular mechanisms directing formation and the detailed molecular 
interactions within this complex. In addition, Rem has been demonstrated to be able to 
partially inhibit L-type current elicited from the overexpression of CaVα1 subunit alone in 
HEK293 cells [57]. Furthermore, Rem-mediated VDCC regulation has been shown to be 
modulated by protein kinase A signaling, presumably through the modulation of 
phosphorylation status of Ser1928 residue located at the distal C-terminus of CaVα1 
subunit [57], although it remains to be determined whether this is true for other RGK 
proteins. These data suggest that the CaVα1 C-terminus also plays a role in Rem-mediated 
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channel regulation. While, the interaction between RGK and CaVβ subunits has been 
established, the issues of whether RGK proteins interact with the CaVα1 C-terminus has 
not understood. Considering the important roles of CaVα1 C-terminus in channel self-
regulation, we first proposed that this domain might play an important role in regulating 
RGK-mediated Ca2+ channel regulation by interacting with RGK proteins. We will 
examine this hypothesis in the following chapters. Importantly, our studies demonstrate 
that RGK proteins directly interact with the proximal CaVα1 C-terminus near the CB-IQ 
domain (Chapter 3), which is essential in generating CDI by directing Ca2+/CaM binding. 
Another important finding is that CaM and Rem appear to compete for CB-IQ domain 
binding and that Rem overexpression alters the kinetics of CDI (Chapter 4). Therefore, 
instead of functioning as absolute Ca2+ channel blockers, RGK proteins may serve as 
endogenous regulators for calcium-dependent channel inactivation in normal physiology. 
This intriguing finding will be addressed in detail in chapter 4.    
Dr. Robert N. Correll from our lab generated Figure 1.1 (used with permission). I 
generated Figure 1.2, 1.3, 1.4, and 1.5. Those figures were modified based on the models 
published in the indicated references listed at the end of each figure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Chunyan Pang 2008 
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 Figure 1.1 RGK proteins interact with a variety of factors to regulate their 
localization and functions.  Human RGK proteins were aligned using ClustalW and 
columns are scored as “*” (residues identical among aligned sequences), “:” (conserved 
substitutions among aligned sequences), or “.” (semi-conserved substitutions among the 
aligned sequences). The putative positions of CaVβ accessory channel subunit, 
calmodulin (CaM), and PIP lipid binding regions are indicated. Residues highlighted in 
green are known to reduce or eliminate CaM binding, while those highlighted in teal 
(basic residues) and orange (hydrophobic residues) are proposed to be involved in PIP 
lipid binding. Residues highlighted in red are phosphorylation sites that have been 
directly confirmed through experimentation with the exception of S18/S290 in mouse 
Rem (and corresponding residues in other RGK proteins) that are thought to be 
phosphorylated based on their roles in 14-3-3 association.  
 
(From Correll RN, Pang C, Niedowicz DM, Finlin BS, Andres DA. Cell Signal 
2008;20(2):292-300.  Used with permission, Elsevier ) 
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extracellular factors (such as LPA) 
 
Figure 1.2 Proposed mechanisms for Gem-mediated cytoskeleton reorganization. 
Two mechanisms have been proposed for Gem-mediated cytoskeleton reorganization. In 
the first, Gem interacts with ROKβ, a Rho GTPase effector protein in a nucleotide-
independent manner. This interaction inhibits the phosphorylation of myosin light chain 
(MLC) and myosin binding subunit (MBS) of the myosin phosphatase, but not LIM 
kinase, and abolishes the formation of myosin–actin filaments, which leads to stress fiber 
and focal adhesion disassembly. In the second, GTP-bound Gem interacts with activated 
membrane-cytoskeleton linker protein Ezrin and directs a Rho-GAP protein Gmip to the 
plasma membrane to inhibit the activity of Rho GTPase. These two mechanisms could 
act synergistically or independently to down-regulate activities of Rho pathways.  
(Modified from Correll RN, Pang C, Niedowicz DM, Finlin BS, Andres DA. Cell Signal 
2008;20(2):292-300.) 
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Figure 1.3 Classification and functions of voltage-dependent calcium channels  
 
 
 Modified From William A. Catterall, Annu. Rev. Cell Dev. Biol. 2000, 16: 521-55. 
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Figure 1.4 Structural organization of voltage-dependent calcium channels (VDCCs) 
VDCCs minimally consist of a pore-forming α1 subunit, an intracellular β subunit, and a 
transmembrane complex α2/δ subunit. The α1 subunit contains four homologous domains 
(I-IV) (not shown) clustering at the plasma membrane to form the ion pore and possesses 
gating functions. The β-subunit is involved in trafficking of α1 subunits. The α2 subunit 
is a highly glycosylated extracellular protein that is connected to the membrane-spanning 
δ-subunit through disulfide bonds.  
 
Modified from Denise Walker and Michel De Waard, Trends in Neurosciences, 1998, 
21(4), 148-154. 
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Figure 1.5 Potential mechanisms underlie RGK-mediated VDCC regulation.  A) 
Regulation of VDCC function by chronic  inhibition of CaVα1 traffick. Left, newly-
synthesized CaVα1 subunits are trapped in the endoplasmic reticulum (ER) because the I-
II loop of CaVα1 has an ER retention signal and association with a CaVβ subunit 
facilitates CaVα1 trafficking to the plasma membrane by antagonizing this retention. 
Center, CaVβ subunits have been found to associate with both CaVα1 and RGK proteins to 
form a complex. This scaffolded complex may interfere with normal channel trafficking. 
Right, RGK proteins sequester CaVβ subunits, rendering them unavailable for CaVα1 
association. Therefore, newly-synthesized CaVα1 subunits are retained in the ER. B) 
Acute regulation of VDCC at the plasma membrane by RGK proteins. RGK proteins are 
proposed to inhibit VDCC activity by forming a trimeric complex with CaVβ/CaVα at the 
plasma membrane. In this mechanism, anchoring of polybasic RGK C-terminus to the 
plasma membrane by interaction with negatively charged PIP lipids is necessary to 
generate channel inhibition.  
(Modified from Correll RN, Pang C, Niedowicz DM, Finlin BS, Andres DA. Cell Signal 
2008;20(2):292-300.) 
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Chapter 2. Materials and Experimental Procedures 
 
2.1 Cell culture 
TsA201 cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen) 
supplemented with 10% fetal bovine serum (Invitrogen) and 10 μg/ml gentamicin 
(GIBCO). HIT-T15 cells were maintained in F-12 Kaighn’s medium (GIBCO) containing 
10% dialyzed horse serum (Invitrogen), 2.5% fetal bovine serum (Invitrogen) and 10 
μg/ml gentamicin (GIBCO). Horse serum was dialyzed against 0.15 M NaCl for three 
times prior to the medium preparation.    
 
2.2 Plasmids    
Cav1.2 plasmid (provided by Dr. T. Kamp, University of Wisconsin) is identical to the 
originally cloned full-length rabbit cardiac Cav1.2 subunit [168] except for alternative 
splicing in domain IV S3 [169]. Rat Cavβ2a plasmid (provided by Dr. E. Perez-Reyes, 
University of Virginia) [170] contains two cysteines residues at the N-terminus which 
undergo palmitoylation and contribute to the plasma membrane localization of the protein 
[83]. GFP-Cav1.2 was kindly provided by K. Beam (University of Colorado Health and 
Sciences Center, Aurora, CO). Full-length CCT-Cav1.2 (1507-2171) (CCT-FL) was 
generated by PCR using GFP-Cav1.2 as the template and the product was subcloned to 
EcoRI/XhoI digested pCDNA3.1+zeo3xHAa [171]. The full-length Cav3.2 CCT, Cav3.2-
(1861-2353) (Cav3.2-CCT), was generated by PCR using pCDNA3-Cav3.2 as the 
template [172] and the product was subcloned to the EcoRI/XhoI sites of 
pCDNA3.1+zeo3xHAa. The truncation mutant plasmids, pCDNA3.1+zeo3xHAa-Cav1.2 
(1507-1905), PCDNA3.1+zeo3xHAa-Cav1.2 (1507-1773), and pCDNA3.1+zeo3xHAa-
Cav1.2 (1507-1669) were generated by introducing stop codons at amino acid residue 
1906, 1774, and 1670, respectively using the Quick change site-directed mutagenesis kit 
(Stratagene, La Jolla, CA). All other CCT truncation mutants were generated by PCR 
using GFP-Cav1.2 as the template and subcloned into the pCDNA3.1+zeo3xHAa vector. 
3xHA-tagged Rem-(1-265)-KCAAX and 3xHA-tagged Rem-(1-265)-HCAAX were 
generated by ligation of oligonucleotide corresponding to the C-terminus of human K-
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Ras4B (171-188) or mouse H-Ras (171-189) to the C-terminus of pCDNA3.1+zeo 
3xHA-Rem-(1-265) using Xbal/Apal sites [56]. 3xFlag-tagged Rem-(1-265)-KCAAX 
and 3xFlag-tagged Rem-(1-265)-HCAAX were generated by PCR and subcloned to the 
HindIII/KpnI sites of p3xFlag-CMV-10. 3xHA-tagged Rem-(1-265)-HSAAX, 3xFlag-
tagged Rem-(1-265)-HSAAX, Cav1.2-(1-1905), and 3xHA-tagged Cav1.2-(1906-
2171)S1928A  were generated using the Quick change site-directed mutagenesis kit 
(Stratagene). Mammalian expression vectors (p3xFlag-CMV-10) for Rem, Rad, and 
Rem2 bearing an N-terminal 3xFlag tag were generated by PCR. Full length CaV1.2-CCT 
(CCT-FL) and the truncation mutants Cav1.2-(1507-1669) (CCT-PX), Cav1.2-(1672-
1905) (CCT-MD), and Cav1.2-(1906-2171) (CCT-DS) were subcloned into pCite4 
(Novagen) for production of in vitro translated proteins. PKH3-mCaM was kindly 
provided by Dr. Dan Noonan from Department of Molecular and Cellular Biochemistry 
at University of Kentucky. All site-directed mutations and PCR reaction products were 
verified by DNA sequence analysis.  
 
2.3 Calcium phosphate transfection 
HBS (2×): Add the following to 900 ml of deionized water: 10 g of tissue culture-tested 
HEPES and 16 g of NaCl. Adjust to pH 7.10 ± 0.05 with 1 M NaOH, adjust the volume 
to 1 l, and sterilize by filtration. The correct pH is critical for good DNA precipitation. 
Phosphate (50×): Combine 70 mM Na2HPO4 with 70 mM NaH2PO4 (1:1) and sterilize by 
autoclaving. 
Calcium chloride: 2 M CaCl2 , and sterilize by filtration. 
Plasmid DNA: Plasmid DNA can be prepared by the standard alkaline lysis procedure 
and purified by CsCl density gradients or by using a variety of commercial ion-exchange 
column methods (BioRad Maxiprep kit has been used to prepare the majority of plasmids 
used in this dissertation). DNA purity is a crucial factor in maintaining high transfection 
efficiency. 
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TsA201 cells were transfected with high efficiency by this calcium phosphate method. 
The following protocol was used to transfect TsA201 cells cultured on 100-mm dish. 
Briefly, 5x106 TsA201 cells were seeded on poly-L-Lysine (0.025 mg/ml in PBS, Sigma) 
coated 100-mm cell culture dish 24 h before the transfection. 25 μg of the desired 
plasmids for transfection was diluted in sterilized dH2O to a total volume of 550 μl. After 
brief vortexing, 75 μl 2M CaCl2 was added. Plasmid mixtures were then mixed again by 
vortexing. Separately, an HBS/phosphate mixture was prepared by adding 20 μl 50 x 
phosphates to 1 ml of 2xHBS buffer. Plasmid mixtures were then added drop-wise to 625 
μl of the HBS/phosphate solution with gentle mixing using a 5 ml sterile polypropylene 
round-bottom tube (Vortex Genie set to shake 2). This transfection mixture was then 
allowed to incubate for 30 min at room temperature. 1 ml of transfection mixture was 
then added drop-wise to the 100-mm dish containing tsA201 cells. These cells were then 
incubated with the transfection mixture at 37°C in a humidified 5% CO2 atmosphere for 
6h. Cells were then washed once with 1xPBS, and re-fed with standard media.   
 
2.4 Recombinant protein production  
Recombinant Rem was expressed as a glutathione S-transferase (GST)-fusion protein. A 
Rem PCR product was generated using PCR and subcloned to BamHI/NheI-digested 
pGEX-KG [173]. PGEX-KG-Rem was transformed into BL21DE3 cells and grew 
overnight, 1 L 2XYT media was inoculated with 10 ml of overnight culture and grown at 
37°C to OD600 of 0.6, cells were then induced with 0.5 mM isopropyl-1-thio-β-D-
galactopyranoside and incubated another 4 h at 37°C before harvesting. The cells were 
lysed with lysozyme (0.5 mg/ml) in GSTB buffer (10 mM Tris PH7.4, 1 mM Mg2+, 10 
μM GDP, 1 mM DTT, and 1 mM PMSF) for 15 min and then subjected to freeze thaw 
for 3 times followed by French press for 3 times. GSTC buffer (20 mM Hepes, PH7.6, 1 
mM Mg2+, 10 μM GDP, 1 mM DTT, 1 mM PMSF, 20% glycerol and 100 mM KCl) was 
added and the cell debris were pelleted at 100,000g for 30 min. Supernatant was then 
incubated with glutathione agarose beads (Sigma) for 30 min with end-over-end rotation 
at 4 °C, washed 3 times with ice-cold GSTC buffer and GST-Rem was eluted with 25 
mM glutathione in GSTC buffer. The eluted protein was then dialyzed against 50 mM 
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Tris, pH 7.5, 150 mM NaCl, 1 mM dithiothreitol, 1 mM Mg2+ and 10% glycerol and 
stored in multiple aliquots at 80 °C. 
 
2.5 In vitro GST pulldown assay   
Radiolabeled CCT-FL, CCT-PX, CCT-MD, and CCT-DS were prepared by in vitro 
transcription and translation in the presence of [35S] methionine using the Single Tube 
Protein System 3 (STP3) kit (Novagen) according to the manufacturer’s instructions. 
pCITE-CCT-FL, -CCT-PX, -CCT-MD, and -CCT-DS were used as template for these 
reactions. Binding of radiolabeled CCT truncation mutants to Rem were assessed as 
follows. Glutathione-Sepharose beads (GE Healthcare) (10 μl) were washed 2 times with 
500 µl of EDTA buffer (50 mM Tris, pH 7.5, 100 mM NaCl, 0.05% Tween 20, 1 mM 
DTT, 1 mM EDTA), resuspended in 1 ml of EDTA buffer, and GST (10 µg) or GST-Rem 
(10 µg) added. The beads were incubated for 5 min with end-over-end rotation at 4 °C, 
washed 2 times with ice-cold EDTA buffer (1 ml), and then with either ice-cold EDTA 
buffer (1 ml), GDP buffer (1 ml) (50 mM Tris, pH 7.5, 100 mM NaCl, 0.05% Tween 20, 
1 mM DTT, 10 mM MgCl2, 20 µM GDP), or GTP buffer (50 mM Tris pH 7.5, 100 mM 
NaCl, 0.05% Tween 20, 1 mM DTT, 10 mM MgCl2, 20 µM GTP S) (1 ml) as indicated 
to facilitate nucleotide exchange. The resin was resuspended in EDTA, GDP, or GTP 
buffer (96 µl total volume) and binding was initiated by the addition of 35S-labeled CCT 
full length or truncation mutants (4 µl). Binding reactions were incubated for 3 h at 4 °C 
with end-over-end rotation and the resin washed three times with incubation buffer to 
remove unbound CCT peptide. GST or GST-Rem was subsequently eluted using two 20-
µl washes of assay buffer supplemented with 25 mM glutathione. The eluted proteins 
were resolved on 10% SDS-PAGE gels, which were dried and exposed to film for 16–72 
h to identify bound [35S]-labeled protein. For those experiments in Figure 4.1, binding of 
CCT-FL or CCT-PX to Rem was performed in a similar manner except that GDP buffer 
containing 2 mM Ca2+ or 5 mM EGTA were used. Purified bovine CaM protein was 
kindly provided by Dr. Thomas Vanaman from Department of Molecular and Cellular 
Biochemistry at University of Kentucky.  
 
2.6 Co-immunoprecipitation analysis   
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3xHA-tagged CCT-FL, CCT-PX, CCT-DS, CCT-MD and either pCDNA3.1+zeo3xHAa 
(control), 3xFlag-tagged Rem, Rem2 or Rad GTPases were cotransfected into tsA201 
cells by the calcium phosphate method[174]. Forty-eight hours post-transfection, the cells 
were washed with PBS, placed into 1 ml of Verseen (GIBCO), harvested, pelleted, and 
then suspended in ice-cold immunoprecipitation (IP) buffer [20 mM Tris, pH 7.5/250 mM 
NaCl/1% TX-100/0.5 mM DTT/1x protease inhibitor mixture (Calbiochem)/10 mM 
MgCl2/10 µM GTPγS]. The cells were lysed by sonication, subjected to centrifugation at 
100,000 X g, and 0.5 mg of the supernatant incubated in a 500-µl reaction containing 12.5 
µl of packed Protein G Sepharose (Pharmacia) and 5 µg of anti-HA monoclonal antibody 
for 3 h with gentle rotation at 4°C. The beads were pelleted and 2.5 µl of the supernatant 
saved for analysis. The beads were then washed three times with 1 ml of IP buffer. The 
supernatant and bound fractions were resolved on SDS/PAGE, transferred to 
nitrocellulose, and subjected to immunoblot analysis using biotinylated-Flag antibody (1 
µg/ml) and  streptavidin–horseradish peroxidase (Pierce) (1:40,000 dilution). Expression 
of 3xFlag-Rem, Rem2 or Rad in whole cell lysates was determined using anti-Flag M2 
monoclonal antibody (1 µg/ml) (Sigma) while the expression of 3xHA-tagged CCT-FL 
or CCT truncation mutants was analyzed using anti-HA monoclonal antibody (1 µg/ml). 
For those experiments shown in Figure 4.2 and Figure 4.3, 3xHA-tagged CCT-PX and 
3xFlag-tagged Rem, Rem-(1-265)-KCAAX or Rem-(1-265)-HCAAX were cotransfected 
into tsA201 cells by the calcium phosphate method. Coimmunoprecipitation and 
immunoblotting analysis was performed in a similar way with the exception that IP 
buffer containing 2 mM Ca2+ or 5 mM EGTA was used for the appropriate analysis.  
 
2.7 Confocal imaging 
TsA201 cells transfected with green fluorescent protein (GFP)-tagged Rem-(1-265)-
HCAAX or GFP-tagged Rem-(1-265)-HSAAX were fixed 2 days after transfection. Cells 
were washed three times with PBS supplemented with 1 mM CaCl2 and 1 mM MgCl2 and 
then fixed in 4% paraformaldehyde on ice for 20 min. Cells were then washed three times 
with PBS and mounted on slides with Vectashield. GFP signal was visualized by using a 
Leica laser scanning confocal inverted microscope  (TCS SP5) equipped with argon laser 
to excite the cells at 488 nm and emission long-pass filtering >505 nm. Cells were 
 37
visualized at 64x magnification. Images displayed are representative of the cells 
observed.   
 
2.8 β Subunit association assay   
3xHA-tagged Rem-(1-265)-HCAAX or 3xHA-tagged Rem-(1-265)-HSAAX was 
cotransfected with Flag-CaVβ1b or pCMV-T7/F2 in tsA201 cells using the calcium 
phosphate method. Forty-eight hours posttransfection, the cells were washed with PBS, 
scraped into 1 ml of Verseen (GIBCO), pelleted, and then suspended in ice-cold 
immunoprecipitation (IP) buffer [20 mM Tris, pH 7.5/250 mM NaCl/1% TX-100/0.5 mM 
DTT/1× protease inhibitor mixture (Calbiochem)/10 mM MgCl2/10 μM GTPγS]. The 
cells were sonicated, subjected to centrifugation at 100,000 X g and 1 mg of the 
supernatant incubated in a 500-μl reaction containing 12.5 μl of packed Protein G 
Sepharose (Pharmacia) coupled to 4 μg of anti-Flag M2 monoclonal antibody (Sigma) for 
3 h with end to end rotation at 4°C. The beads were pelleted and washed three times with 
1 ml of IP buffer. The bound proteins were then released by adding 20 μl 2xSDS loading 
buffer and boiling for 5 min. The released proteins were resolved on 10% SDS/PAGE, 
transferred to nitrocellulose, and subjected to immunoblot analysis. Biotin-HA (1 μg/ml) 
was used to detect Rem-(1-265)-HCAAX or Rem-(1-265)-HSAAX in the pelleted 
fraction. Biotin-Flag (1 μg/ml) was used to detect Flag-CaVβ1b in the pelleted fraction. 
The expression of 3xHA-tagged Rem-(1-265)-HCAAX or 3xHA-tagged Rem-(1-265)-
HSAAX was analyzed using anti-HA monoclonal antibody (1 µg/ml). 
 
2.9 Calmodulin binding assay 
TsA201 cells were maintained in Dulbecco's modified Eagle's medium (Invitrogen) 
supplemented with 10% fetal bovine serum (Invitrogen) and transfected with the 3xFlag 
tagged Rem, Rem-(1-265), Rem-(1-265)-KCAAX, Rem-(1-265)-HCAAX or empty 
p3xFlag-CMV10 as the control using the calcium phosphate method[174]. 48 h post-
transfection, cells were harvested and lysed in calmodulin immunoprecipitation buffer (50 
mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.5% Nonidet P-40, 1x phosphatase inhibitor 
mixture II (Calbiochem), 1x protease inhibitor mixture I (Calbiochem), 1 mM 
phenylmethylsulfonyl fluoride), sonicated, and centrifuged at 100,000 x g. Calmodulin-
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Sepharose beads (GE Healthcare) were washed twice with immunoprecipitation buffer 
and incubated with 1 mg of total lysate in the presence of 2 mM CaCl2 for 2 h with end-
over-end rotation at 4 °C. Beads were then washed three times in immunoprecipitation 
buffer containing 2 mM CaCl2, and proteins were released from the beads with two 20 μl 
washes of assay buffer containing 5mM EGTA. The eluted protein were resolved on 10% 
SDS-PAGE minigels and transferred to nitrocellulose membranes. Interaction of Rem 
proteins with calmodulin was examined by immunoblot with anti-Flag M2 monoclonal 
antibody (1 μg/ml) (Sigma).  
 
2.10 Electrophysiology  
 TsA201 cells were transfected with the indicated plasmids using the calcium phosphate 
method, and whole-cell patch clamp experiments were performed [56, 154]. HIT-T15 
cells were transiently transfected with the indicated plasmids at 48 h before recording 
using lipofectamine reagent (Invitrogen). Transfected cells were identified by GFP 
expression. The whole cell configuration of the patch-clamp technique was used to 
measure ionic current. Patch pipettes with resistances of 1.5-2 mΩ were pulled from 
micropipette glass (VWR Scientific) and fire-polished prior to use. Patch electrodes 
contained (in mM) 110 K-gluconate (or 0), 40 CsCl (or 150), 3 EGTA, 1 MgCl2, 5 Mg-
ATP, and 5 HEPES, PH 7.36. The bath solution consisted of (in mM) 112.5 CsCl, 30 
BaCl2 or CaCl2, 1 MgCl2, 10 tetraethylammonium chloride, 5 glucose, 5 HEPES, PH 7.4. 
For both tsA201 and HIT-T15 cells, only those cells with the capacitance less than 15 pF, 
series resistance less than 1.2 MOhm were used for data analyis. Approximately 70-80% 
of series resistance was compensated with the patch clamp circuitry. In order to eliminate 
the contamination of T-type currents elicited from HIT-T15 cells during depolarization, 
two protocols were used to record ionic currents derived from any specific cell. In the 
first protocol, the I-V relationship was determined by applying 1000 ms voltage pulses at 
0.25 Hz to potentials between -90 and 80 mV in 5 mV increments from a holding 
potential of -80 mV. For the second protocol, HIT-T15 cells were stimulated at -50 mV 
for 200 ms before a series of voltage pulses from -50 mV to 80 mV were applied in 5 mV 
increments from a holding potential of -80 mV. This protocol efficiently suppressed 
contaminating T-type currents observed in the patch-clamping of HIT-T15 cells, which 
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are activated at much more negative potentials than L-type currents [71, 175]. Leak 
subtraction and L-type current were obtained by the combination of those two protocols. 
Signals were amplified with an Axopatch 200B amplifier and 333 kHz A/D system 
(Axon Instruments, Union City, CA). Data was analyzed with Clampfit 9 (Axon 
Instruments) and Origin statistical software (OriginLab, Northampton, MA). All 
recordings were performed at room temperature (20-22°C). In Figure 3.6, Peak current 
values were reported as mean at 15 mV ± SE, and statistical significance was determined 
using student’s t-test with p-values of <0.05. In Figure 4.4C and Figure 4.4D, peak 
current values were reported as mean at 5 mV ± SE and 20 mV ± SE, respectively; and 
statistical significance was determined using Kruskal-Wallis test followed by a post hoc 
Dunn’s test with p-values of <0.01 (Graphpad prism5). For the data analysis in Figure 
4.6C, the degree of VDI was analyzed using r600, the ratio of the residual current values at 
600 ms and at the initial peak. For the data analysis shown in Figure 4.6D, Ca2+ currents 
recorded during a typical 1000 ms test pulse applied ranging from 0 mV to +40 mV from 
a holding potential of -80 mV at indicated experimental conditions were analyzed using 
pclamp10 software and the time constants of inactivation were derived from fitting the 
decay phases of the time courses with the following biexponential function equation: i(t) 
=A1* exp( t /Taufast) + A2 * exp( t/Tauslow) + C, where t is the time; A1, A2, Taufast, and 
Tauslow are the amplitudes and time constants of the fast or slow exponential components; 
and C is the fraction of noninactivating current. The fast component of the time constant 
of inactivation (taufast) is generated primarily by Ca2+-mediated CaM binding-induced 
conformational change to the CCT, the major player in generating CDI [128, 138]. The 
value of taufast provides a way to determine the rate of channel inactivation, with smaller 
values indicating faster inactivation. 
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Chapter 3. The Cav1.2 C-terminus Interacts with Rem and 
Contributes to Rem-Mediated Calcium Channel Inhibition 
 
3.1 Introduction 
High voltage activated (HVA) Ca2+ channels modulate Ca2+ influx upon membrane 
depolarization to regulate a wide variety of cellular functions including neurotransmitter 
release, hormone secretion or muscle contraction [71]. VDCCs minimally consist of a 
pore-forming α1 subunit, an intracellular β subunit, and a transmembrane complex α2/δ 
[71], with each of the subunits contributing to the modulation of the kinetics and voltage-
dependence of channel gating properties [71, 88]. Intracellular domains of the pore-
forming α1 subunit serve as scaffolds for the targeting and localization of a diverse array 
of regulatory molecules. A conserved α1 interaction domain (AID) located between the 
first and second repeats of the Cavα1-subunit (loop I-II), serves as a high affinity binding 
site for all Cavβ subunits [176] and AID:CaVβ association promotes trafficking of channel 
complex to the plasma membrane and results in increased current densities [83, 84, 153].  
The Cavα1-subunit C-terminus (CCT), which constitutes approximately 30% of the total 
mass of the protein, serves as another major site of modulation [177]. The L-type channel 
CCT (residues 1507-2171 for rabbit CaV1.2) serves as the target of various cellular 
signaling pathways, including PKA, PKC, CaM, CaMKII, and protein phosphatases PP1 
and PP2A [71, 121, 178]. A conserved CB/IQ domain and regions proximal to the CB/IQ 
have been reported to contribute to channel auto-regulation, including Ca2+–dependent 
inactivation (CDI) through Ca2+-regulated interactions with calmodulin (CaM) [138].  
Phosphorylation of the α1 subunit by cAMP-dependent protein kinase (PKA) leads to a 
marked enhancement of Ca2+ current in cardiac myocytes [179] and the major 
phosphorylation site in the Cav1.2 CCT has been identified as Ser1928 [101].   
The expression of exogenous RGK proteins has been shown to potently inhibit high-
voltage activated (HVA) Ca2+ channel activity in both heterologous and native systems 
[52, 55, 57, 58, 155, 156, 158, 163], mediated in part through interactions of the RGK 
GTP-binding core with auxiliary β-subunits and association of the conserved RGK C-
terminus with the plasma membrane [56, 163]. Recent studies have also provided 
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evidence in support of a role for the Cavα1-CCT in Rem-dependent channel regulation 
[57]. In this study, we strengthen these data by identifying a direct interaction between 
Rem and the CCT from L-type, but not T-type Ca2+ channels, which are resistant to RGK 
regulation [52, 58]. The Rem2 and Rad proteins also associate with the CCT, suggesting 
that this domain represents a common binding target for all RGK proteins.  Fine mapping 
demonstrates that the CB-IQ domain in CaV1.2 plays an essential role in directing Rem-
CCT association, and co-expression of the proximal CCT domain with Rem results in the 
partial recovery of ionic current in HIT-T15 cells. Furthermore, while Rem:CaVβ 
association alone is not sufficient to generate channel inhibition, Rem:CCT association is 
well correlated with both the plasma membrane localization of Rem and more 
importantly, channel regulation. These results suggest that CaVα1-CCT association plays 
a critical role in Rem-mediated Ca2+ channel regulation.   
I generated all of the data shown in Figure 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, and 3.7. Dr. 
Brian S. Finlin from our lab kindly provided the purified GST-Rem-(1-265) used for 
experiments shown in Figure 3.2 (C). Dr. Robert N. Correll from our lab generated the 
GFP-Rem-(1-265)-HRas-CAAX construct and provided the confocal microscopy picture 
for this chimeric protein shown in Figure 3.8. I generated the GFP-Rem-(1-265)-HRas-
SAAX construct and produced the confocal microscopy picture for this protein shown in 
Figure 3.8.  
 
3.2 Results 
 
3.2.1 Rem interacts with the L-type, but not T-type CaVα1-CCT  
Rem inhibits ICa,L in part through association with auxiliary CaVβ subunits [55, 56, 
58, 155, 156], but the contribution of the channel α1-subunit to Rem regulation remains 
incompletely characterized [163]. Our recent studies demonstrated that protein kinase A 
(PKA) signaling, potentially acting through phosphorylation of the CaV1.2 α-subunit C-
terminus (CCT), contributes to Rem-mediated inhibition of CaV1.2 currents [57]. To 
explore whether Rem interacts with the CCT, tsA201 cells were transiently co-transfected 
with expression vectors encoding 3xFlag-tagged Rem and either 3xHA-empty vector 
(control), 3xHA-tagged full-length CCT, or the indicated CCT truncation mutants (Figure 
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3.1A, B). HA-CCT or the CCT mutants were then isolated by immunoprecipitation, and 
bound Flag-Rem was visualized by immunoblotting. As seen in Figure. 3.1B, Rem was 
found to associate with full-length CCT (CCT-FL) (Figure 3.1B, top panel). This binding 
appears to involve interactions of Rem with both the proximal (Cav1.2 (1507-1669) 
(CCT-PX)) and distal (Cav1.2 (1906-2171) (CCT-DS)) domains, but not with the medial 
(Cav1.2 (1672-1905) (CCT-MD)) portion of the CaV1.2-CCT (Figure 3.1B, top panel). 
Although not all the CCT fragments were expressed at equivalent levels (Figure 3.1C), 
CCT-MD was highly expressed and immunoblotting confirmed that the transfected cells 
expressed similar levels of 3xFlag-Rem (Figure 3.1B, lower panel).  
RGK proteins are incapable of inhibiting T-type calcium channel function [52, 58], 
and the CCT domains of L- and T-type α-subunits display little overall sequence 
homology [180]. Therefore, as an added specificity control, we examined the interaction 
between Rem and the CaV3.2-CCT. Although the Cav3.2-CCT was expressed at greater 
levels than that of Cav1.2-CCT in tsA-201 cells (Figure 3.1D, bottom panel), Rem failed 
to interact with Cav3.2-CCT (Figure 3.1D, top panel). Taken together, these studies 
indicate that Rem interacts with both the proximal and distal portions of the L-type CCT, 
but not with the T-type CCT.  
 
3.2.2 RGK proteins associate directly with the proximal CCT in a nucleotide-
independent manner 
To further characterize the nature of the Rem-CCT association, we next used 35S-
labeled, in vitro translated CCT fragments and recombinant glutathione-S-transferase 
(GST) fused Rem (GST-Rem) and GST-Rem-(1-265) to explore the Rem-CCT 
interaction. The generation of 35S-labeled CCT-FL or the other three CCT truncation 
mutants is shown in Figure 3.2A. GST-Rem directly bound 35S-labeled CCT-PX, but 
failed to associate with CCT-MD.  Interestingly, Rem did not interact with CCT-DS 
(Figure 3.2B), suggesting that Rem binding with the distal CCT requires additional 
cellular binding factors since the interaction was detected when Rem and CCT were co-
overexpressed in tsA201 cells (Fig 3.1B). Surprisingly, the conserved RGK C-terminus 
appears to contribute to CCT binding, since GST-Rem-(1-265) failed to associate with 
either CCT-FL or CCT-PX (Figure 3.2C). In addition, while previous work has suggested 
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that RGK-mediated Ca2+ channel regulation may be GTP-dependent [55, 158], CCT 
binding to Rem was found to be nucleotide-independent, with both GDP-bound and 
GTPγS-bound Rem displaying equivalent in vitro CCT-PX binding (Figure 3.2B).   
 Since the in vitro binding data indicates that the CCT-PX region is a direct 
binding target for Rem within the CCT, to identify the minimum structural sequence in 
CCT-PX responsible for Rem association, a series of CCT truncation mutants were 
generated (Figure 3.3A) and assessed for their ability to associate with Rem by co-
immunoprecipitation. As seen in Figure 3.3B, CCT-(1507-1905), CCT-(1507-1733), and 
CCT-(1507-1669) were all capable of interacting with Rem, indicating that residues 
beyond the CB-IQ domain do not enhance Rem association. Importantly, while the CCT-
(1609-1905) truncation mutant which contains the CB-IQ region [129, 138, 145] but 
deletes many of the well conserved structural domains from CCT, including the EF hand 
[181, 182] and peptide A [137, 145] regions, retained Rem binding, the larger CCT-
(1672-1905) truncation, which does not contain the CB-IQ domain, failed to demonstrate 
any Rem interaction. This was not the result of reduced CCT mutant expression, as all of 
the mutants displayed similar levels of expression (Figure 3.3B, bottom panel). Taken 
together, this analysis indicates that Rem-CCT association requires the well conserved 
CB-IQ domain found in all HVA Ca2+ channels [142].    
 If CCT association is required for RGK-mediated channel regulation, we reasoned 
that CCT binding should be a common property for all RGK proteins. Importantly, when 
expressed in tsA201 cells, both Rem2 and Rad GTPases co-immunoprecipitate with the 
proximal and distal domains, but not the medial domain, of CCT (Figures 3.4A and 
3.4B). Thus, the ability to interact with CCT is a conserved property for RGK family 
proteins and suggests that CCT association may contribute to RGK-mediated channel 
regulation. 
 
3.2.3 CCT-DS is not required for Rem-mediated L-type ionic current inhibition 
        The fact that an interaction between CCT-DS and Rem was identified when  co-
overexpressed in tsA201 cells (Figure 3.1B), but was not seen following the incubation of 
purified GST-Rem with radiolabeled in vitro-translated CCT-DS (Figure 3.2B), suggests 
that additional intracellular scaffold protein(s) may be required to facilitate this 
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association. To further evaluate the importance of CCT-DS in Rem-mediated Ca2+ 
channel inhibition, tsA201 cells were transiently co-transfected with a Cav1.2 distal C-
terminal truncation mutant Cav1.2-(1-1905), β1b and either empty GFP or GFP-Rem. 
While control cells expressing Cav1.2-(1-1905)+β1b+GFP displayed >9 pA/pF peak 
inward current (Figure 3.5A, filled squares, -9.2 ± 2.3 pA/pF, n=12), coexpression of 
GFP-Rem with β1b and Cav1.2-(1-1905) generated a complete block of ionic current 
expression (Figure 3.5A, filled circles, -0.1 ± 0.1 pA/pF, n=8). Therefore, CCT-DS is not 
essential for Rem-mediated L-type Ca2+-channel inhibition. Previous studies have 
suggested that PKA-mediated phosphorylation of Ser1928, located within the CCT-DS 
domain, contributes to Rem-mediated inhibition of CaV1.2 currents [57]. To explore the 
role of Ser1928 phosphorylation in the association of CCT-DS and Rem, Ser1928 was 
substituted to Ala in CCT-DS and the interaction between Rem and CCT-DSser1928A was 
examined. As seen in Figure 3.5B, mutation of Ser1928 to Ala did not affect the 
association between Rem and CCT-DS, indicating that the phosphorylation of Ser1928 is 
not essential for the interaction between Rem and CCT-DS. Immunoblotting confirmed 
that the transfected cells expressed similar levels of 3xFlag-Rem, CCT-DS, or CCT-
DSser1928A (Figure 3.5B). Since CCT-DS does not appear to contribute to Rem-mediated 
L-type Ca2+ channel inhibition, we focused the remaining studies on determining the 
importance of the Rem:CCT-PX interaction to Rem-mediated Ca2+ channel regulation. 
 
3.2.4 CCT association is important for Rem-mediated channel regulation  
To explore the significance of CCT association, we next examined the effect of 
CCT-PX and CCT-MD overexpression on Rem-dependent channel regulation in HIT-
T15 cells. HIT-T15 cells were used because those cells express endogenous L-type Ca2+ 
channels, allowing us to reduce the number of plasmids used for transfection. Because 
neither CCT fragment is expected to modulate CaVα1 function, but CCT-PX retains the 
ability to bind Rem (Figures 3.1 and 3.2), we reasoned that CCT-PX expression would 
not directly modulate Ca2+ channel function but might compete with endogenous L-type 
channels for Rem association. HIT-T15 cells transiently co-transfected to express 
unfused green fluorescent protein (GFP) and 3xHA-empty vector display >11 pA/pF 
peak inward current (Figure 3.6A, filled triangles, -11.3 ± 1.9 pA/pF, n=9). Consistent 
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with the notion that the CCT-PX and CCT-MD fragments alone do not modulate Ca2+ 
channel activity in terms of current density or voltage-dependent channel gating 
properties, co-expression of GFP with either HA-tagged CCT-PX or HA-CCT-MD had 
no effect on current amplitude or voltage-dependent channel activation (Figure 3.6A, -
13.3 ± 1.8 pA/pF for HA-CCT-PX, filled circles, n=6; -13.9 ± 4.5 pA/pF for HA-CCT-
MD, open squares, n=7) (Figure 3.6B, currents at 15 mV from Figure 3.6A). As we have 
described previously [57, 155], co-expression of GFP-Rem with 3xHA empty vector in 
HIT-T15 cells results in the absence of detectable ionic current expression (Figure 3.6C, 
0.1 ± 0.4 pA/pF, n=9), and importantly, co-expression of HA-CCT-PX, but not HA-CCT-
MD, was able to partially relieve the Rem blockade of ionic current (Figure 3.6C). In 
these experiments, CCT-PX expression resulted in a statistically significant (student’s t-
test, p<0.05) increase in peak current amplitude to >2 pA/pF (-2.0 ± 0.9 pA/pF, n=13), 
while CCT-MD expression had no effect on Rem-mediated current blockade (0.4 ± 0.5 
pA/pF, n=15). Taken together, these data suggest that CCT association plays a critical 
role in Rem-mediated channel regulation. 
 
3.2.5 Plasma membrane targeting is essential for Rem:CCT association when co-
overexpressed in tsA201 cells 
To determine whether the Rem C-terminus is required for CCT association, we next 
analyzed the binding of wild-type Rem or Rem-(1-265) to CCT-PX in a coexpression 
system. Consistent with our previous results (Figure 3.2C), Rem-(1-265) failed to co-
immunoprecipitate HA-CCT-PX, whereas full-length Rem bound the proximal CCT 
(Figure 3.7A).  We next investigated whether the Rem C-terminus directly contributed to 
CCT binding, or if the effect was indirect, perhaps resulting from differential Rem 
subcellular localization. For these studies, we made use of two chimeric proteins in which 
the C-terminus of K-Ras4B and H-Ras were fused to Rem-(1-265) [56]. We previously 
showed that fusion of these CAAX plasma membrane trafficking motifs to Rem-(1-265) 
restores both membrane localization and Ca2+ channel regulation [56], and co-
immunoprecipitation analysis found that both chimeric proteins were capable of binding 
CCT-PX (Figure 3.7A). Therefore, Rem:CCT association is correlated with both Rem-
mediated Ca2+ channel regulation and plasma membrane localization, but does not appear 
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to require the conserved Rem C-terminus. To strengthen this correlation, we generated 
Rem-(1-265)-HSAAX, a mutant in which the CAAX motif cysteine residue was mutated 
to serine, disrupting both prenylation of the H-Ras membrane targeting domain and 
membrane trafficking for C/SAAX mutant [183-185].  Confocal microscopy confirmed 
that Rem-(1-265)-HSAAX was no longer localized to the plasma membrane (Figure 3.8) 
and co-immunoprecipitation studies found that while this mutant fails to associate with 
CCT-FL (Figure 3.7B), it retains Cavβ1b subunit binding (Figure 3.7C). In addition, while 
GFP-Rem-(1-265)-HCAAX expression resulted in a potent reduction in ionic current 
expression (-1.1 ± 0.3 pA/pF, closed triangles, n=8) when co-expressed with Cav1.2+β1b 
in tsA201 cells (Figure 3.7D), GFP-Rem-(1-265)-HSAAX did not significantly alter Ca2+ 
channel function (Figure 3.7D). Whole cell currents elicited in the presence of 
Cav1.2+β1b+GFP-Rem-(1-265)-HSAAX (-17.7 ± 3.9 pA/pF, filled squares, n=9) were 
indistinguishable from control currents in cells expressing Cav1.2+β1b+GFP (-18.5 ± 4.7 
pA/pF, open circles, n=10) (Figure 3.7D). Taken together, these data indicate that, 
plasma membrane targeting, but not sequences within the C-terminus, are critical for 
Rem:CCT association and further support the notion that CCT binding is necessary for 
effective Rem-mediated channel regulation.    
 
3.3 Discussion 
All members of RGK GTPases act to inhibit high-voltage activated (HVA) Ca2+ 
channel function [25, 44, 46, 47, 52, 55, 57, 58, 155, 156, 158, 163]. Interaction between 
RGK proteins and accessory CaVβ subunits contributes to RGK-mediated HVA Ca2+ 
channel function [55, 57, 58, 155, 156, 158], although CaVβ binding alone is not 
sufficient for Rem-dependent current blockade [56, 162]. In this chapter, we provide new 
insight into the mechanisms of RGK-mediated Ca2+ channel regulation through the 
identification of the interaction between the HVA CaVα1-CCT and RGK GTPases and 
find that Rem-dependent regulation of HVA Ca2+ channel current appears to require 
association with the proximal CCT (Figure 3.6). Thus, in addition to CaVβ association 
and plasma membrane localization, these data suggest that interaction with the CB/IQ 
region within the proximal CCT is important for RGK-mediated Ca2+ channel inhibition. 
Based upon these findings we propose that RGK proteins interact with both Cavβ and 
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CCT to promote reorganization of CaVα1 intracellular domains to generate the blockade 
of current expression which is the hallmark of RGK-dependent Ca2+ channel regulation 
[25, 44, 46, 47, 52, 55, 57, 58, 155, 156, 158, 163].  
Rem, Rad, and Rem2 are each capable of interacting with both the proximal 
(residues 1507-1669) and the distal (residues 1906-2171) domains of the CaV1.2-CCT 
(Figures 3.1, 3.3, 3.4) when co-overexpressed in tsA201 cells. However, in vitro binding 
studies using recombinant Rem suggest that the interaction between Rem and CCT-PX is 
direct, while that with the CCT-DS domain is indirect and may require an unknown 
intracellular anchoring protein(s) (Figure 3.2B). Since the proximal CCT domains of all 
HVA Ca2+ channel share greater than 50% amino acid identity, but share less that 10% 
identity with the same region within the low voltage activated T-type channels, the 
finding that Rem does not associate with the T-type CCT is not surprising (Figure 3.1D). 
Interestingly, the proximal CCT contains several functionally important domains 
including the conserved EF-hand, A, CB and IQ domains, all of which have established 
regulatory roles in L-type Ca2+ channel function. In particular, the A, CB and IQ domains 
all have been reported to serve as docking sites for both apocalmodulin (ApoCaM) and 
Ca2+-CaM [138]. Although the identity of the exact binding sites for ApoCaM and Ca2+-
CaM on the CCT remain controversial, and appear to be dependent on the functional 
status of the particular channel under study [138], it has been proposed that Ca2+ binding 
to CaM elicits a major conformational change in the CCT which initiates calcium-
dependent inactivation (CDI) [139, 145]. Fine deletion mapping studies indicated that 
Rem binding requires the CB-IQ region (Figure 3.3B), suggesting that Rem binding could 
alter the interaction of the proximal CCT domain with CaM. It is possible that either 
disruption of the normal interactions of CaM with the CCT, or Rem binding-mediated 
conformational reorganization of the proximal CCT, could contribute to Rem-dependent 
Ca2+ channel blockade. Resolution of how RGK binding might alter CCT domain 
structure will require additional studies, but structural analysis of a RGK family member-
CaVβ-CaVα-CCT complex may be necessary to fully understand the role of Rem binding 
in Ca2+ channel inhibition. The recent solution of both Gem and Rad GTPase crystal 
structures are important first steps in this process [7-9].  
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To assess the importance of Rem:CCT-PX association for Ca2+ channel regulation, 
the ability of CCT-PX co-expression to relieve Rem-mediated current blockade was 
examined. While expression of 3xHA-tagged CCT-PX in HIT-T15 cells did not cause 
any significant changes to endogenous L-type Ca2+ channel activity (Figure 3.6A,B), co-
expression of HA-CCT-PX was found to partially relieve Rem-dependent Ca2+ channel 
inhibition (Figure 3.6C). A similar experimental approach was recently used to implicate 
the importance of β-subunit association in Rem-mediated channel regulation [155]. Since 
RGK-mediated Ca2+ channel regulation has been reported to be dose-dependent [156], 
this recovery likely results from the partial disruption of the interaction between Rem and 
the CCT of endogenous HIT-T15 Ca2+ channels by the exogenous CCT-PX peptide. 
Taken together, these data support a crucial role for CCT-PX association in Rem-
mediated Ca2+ channel regulation 
        Our studies also indicate that RGK proteins interact with the distal CCT when co-
overexpresssed in tsA201 cells (Figures 3.1B, 3.4A, and3.4 B). Since there is only 
limited sequence conservation within the CCT-DS domains among Cav1 and Cav2 
channels (approximately 10% amino acid conservation within Cav1 and Cav2 channels) 
[71], we suspected that Rem association might not involve a direct interaction. Indeed, 
our inability to detect binding when mixing purified Rem and in vitro translated CCT-DS 
(Figure 3.2B), strongly suggests that an additional intracellular factor(s) is required to 
facilitate the association between Rem and CCT-DS. In skeletal and cardiac muscle, the 
distal C-terminus of L-type calcium channels undergoes proteolytic cleavage [102, 186, 
187], and the released distal fragment functions as an autoinhibitory domain [149, 150].  
More recently, the CCT-DX domain has been reported to regulate gene transcription, 
translocating to the nucleus in response to low Ca2+ concentrations [152]. Although the 
CCT-DS has been reported to play important roles in regulating both channel activity and 
gene expression [57, 152], our studies indicate that the CCT-DS domain  is not required 
for Rem-mediated L-type Ca2+ channel inhibition since Rem was still capable of  
inhibiting Ca2+ channel function in a truncated channel lacking the CCT-DS domain 
(Figure 3.5A). Phosphorylation of CaVα1 by cAMP-dependent protein kinase (PKA) leads 
to enhanced Ca2+ current in cardiac myocytes  [179] and Ser1928 has been identified as a 
major target for PKA signaling [101] within the distal CCT. Although PKA inhibition 
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partially relieves Rem-mediated L-type Ca2+ channel blockade [57], our studies indicate 
that the phosphorylation of Ser1928 is not essential for directing Rem:CCT-DX association 
(Figure 3.5B). Therefore, the CCT-DS does not appear to play an essential role in Rem-
dependent L-type Ca2+ channel regulation. 
Recent studies have suggested that both RGK-dependent CaVβ subunit association 
[44, 46, 47, 55, 158] and HVA Ca2+ channel regulation are GTP-dependent processes. 
For the majority of Ras family GTPases, the effector domain serves as the primary 
interaction site for cellular binding proteins and this site is usually conserved within 
subfamilies of Ras-related GTPases with similar physiological functions [1]. However, 
the putative effector domains within the RGK proteins are poorly conserved [4, 8], 
suggesting that this region is unlikely to direct binding to common cellular targets [163], 
including both CaVβ-subunits and the CaVα1-CCT. While it is possible that individual 
RGK proteins use distinct mechanisms to down-regulate HVA Ca2+ channel function, the 
association of Rem and Rem2 with Cavβ has been found to be nucleotide-independent 
[61, 155], proximal CCT binding does not require GTP-bound Rem (Figure 3.2B), and 
Rem2-mediated inhibition of ICa,L in superior cervical ganglion neurons is nucleotide-
independent [52]. Clearly, the GTP-dependence of RGK-mediated HVA Ca2+ channel 
regulation, and the identification of the CaVβ and CCT binding domains within the RGK 
GTPases will require further investigation.   
In summary, we demonstrate here that RGK proteins are capable of interacting with 
two distinct domains within the CaV1.2-CCT, including a direct interaction that requires 
the CB/IQ domain within the proximal C-terminus. Furthermore, while plasma 
membrane localization is necessary for Rem:CCT association and Ca2+ channel 
regulation, it is dispensable for β subunit binding, suggesting that the Rem:CCT 
interaction plays an important role in Rem-mediated HVA Ca2+ channel regulation.  
These data, together with studies of RGK-CaVβ association [55, 56, 58, 155, 156, 162], 
suggest a model in which CaVβ serves a scaffolding role, promoting formation of a stable 
RGK-CaVβ-AID complex, which in turn interacts with the CB/IQ region of the CCT to 
promote channel inhibition. This is reminiscent of recent models for Ca2+-dependent 
inactivation (CDI) in which Ca2+-calmodulin binding to the CCT facilitates interaction of 
the AID region with the proximal C-terminus of CaVα1 [138, 145].  Regulation of RGK-
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dependent Ca2+ channel inhibition appears to rely, in part, on the interaction of the 
conserved RGK C-terminus with PIP membrane lipids [56, 61]. However, additional 
studies will be needed to identify the cellular signaling pathways that control Rem-
mediated HVA Ca2+ channel activity and the interplay between Rem:CCT and Rem:Cavβ 
binding in Ca2+ channel inhibition. 
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Figure 3.1 Rem interacts with both the proximal and distal domains of CCT  
A Schematic of the CCT truncation mutants, the Rem interaction status is indicated on 
the right. B, The ability of Rem to interact with two domains of the CCT was assessed by 
co-immunoprecipitation. TsA201 cells were transiently co-transfected with expression 
vectors encoding 3xFlag-tagged Rem and either PCDNA3.1+3xHAa (3xHA empty 
vector), 3xHA-tagged CCT-FL or the indicated CCT truncation mutants. 48 h post-
transfection, cells were harvested, and 0.5 mg cell lysate was subjected to 
immunoprecipitation with anti-HA antibody as described in “Chapter 2”. The entire 
bound fraction or 2.5 μl of the unbound fraction was analyzed by immunoblotting with 
biotin-Flag to detect Rem. C, 5 μg cell lysate was immunoblotted with anti-HA to detect 
CCT-FL and the corresponding truncation mutants used in Figure 3.1B. D, The ability of 
Rem to interact with Cav3.2 CCT was assessed by co-immunoprecipitation. TsA201 cells 
were transiently co-transfected with expression vectors encoding 3xFlag-tagged Rem and 
either PCDNA3.1+3xHAa (3xHA empty vector), 3xHA-tagged Cav1.2 CCT or 3xHA-
tagged Cav3.2 CCT. Coimmunoprecipitation was performed with HA antibody as 
described in B and interaction with Rem examined by immunoblotting with biotin-Flag 
antibody. 5 μg cell lysate was immunoblotted with anti-Flag or anti-HA to determine the 
expression level of Rem or Cav1.2 and Cav3.2 CCT, respectively.   
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Figure 3.2 Rem interacts with CCT-PX in vitro 
A, The indicated 35S-labeled CCT truncation mutants were prepared by in vitro 
transcription and translation as described under “Experimental Procedures”. The 35S-
labeled proteins were resolved on 10% SDS-PAGE gels, which were then dried and 
exposed to film for 3 h. B, Recombinant GST or GST-Rem proteins coupled to GST 
beads were preloaded with the indicated nucleotide, incubated with 35S-labeled CCT 
truncation mutants for 3h at 4°C. The GST beads were then pelleted and washed as 
described in “Chapter 2”. The bound fractions were subjected to SDS-PAGE, and the 
dried gel was exposed to film for 16-72 h. C, Recombinant GST, GST-Rem, or GST-
Rem-(1-265) proteins coupled to GST beads were preloaded with GDP, incubated with 
35S-labeled CCT-FL or CCT-PX for 3 h at 4°C. The GST beads were then pelleted and 
washed as described in “Chapter 2”. The bound fractions were subjected to SDS-PAGE, 
and the dried gel was exposed to film for 24 h.  
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Figure 3.3 CB-IQ domain is required for the interaction between CCT-PX and Rem. 
A, Schematic of the CCT truncation mutants in the proximal domain, the Rem interaction 
status is indicated on the right. B, Fine mapping of the Rem association domain within 
CCT-PX was performed by co-immunoprecipitation. TsA201 cells expressing 3xFlag-
Rem and either pCDNA3.1+3xHAa (3xHA empty vector) or the indicated 3xHA-tagged 
CCT truncation mutants were subjected to anti-HA immunoprecipitation as described in 
Figure 3.1. Rem association was determined by immunoblotting the bound fraction with 
biotin-Flag antibody (top panel). 2.5 μl supernatant was immunoblotted with biotin-Flag 
to detect Rem. 5 μg cell lysate was immunoblotted with anti-HA to determine the 
expression level of CCT truncation mutants (bottom panel).     
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Figure 3.4 Rem2 and Rad interact with both of the proximal and distal domains of 
CCT 
A, The interaction of Rem2 and Rad with CCT was assessed by co-immunoprecipitation 
analysis. TsA201 cells were transiently co-transfected with expression vectors encoding 
3xFlag-tagged Rem2 and either pCDNA3.1+3xHAa (3xHA empty vector), 3xHA-tagged 
CCT-FL or the indicated CCT truncation mutants. The ability of 3xFlag-tagged Rem2 to 
interact with either CCT-FL or the indicated truncation mutants was determined by co-
immunoprecipitation analysis as described in “Chapter 2”. 2.5 μl supernatant was 
immunoblotted with biotin-Flag to detect unbound Rem2. 5 μg cell lysate was 
immunoblotted with anti-HA to detect CCT-FL and the corresponding CCT truncation 
mutants (bottom panel). B, TsA201 cells were transiently co-transfected with expression 
vectors encoding 3xFlag-tagged Rad and either pCDNA3.1+3xHAa (3xHA empty 
vector), 3xHA-tagged CCT-FL or the indicated CCT truncation mutants. Co-
immunoprecipitation analysis was performed as described in A. 
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Figure 3.5 CCT-DS is not essential for Rem-mediated L-type Ca2+ current inhibition 
A, TsA201 cells were transfected with plasmids expressing Cav1.21-1905, β1b and either 
GFP-Rem or unfused GFP as a control. Current was examined using the whole-cell patch 
clamp configuration in the presence of 30 mM Ba2+. B, Phosphorylation of Ser1928 located 
in CCT-DS domain is not required for Rem:CCT-DS association. TsA201 cells were 
transiently co-transfected with expression vectors encoding 3xFlag-tagged Rem and 
either pCDNA3.1+3xHAa (3xHA empty vector), 3xHA-tagged CCT-DS or 3xHA-tagged 
CCT-DSS1928A. Coimmunoprecipitation was performed with HA antibody as described in 
chapter 2 and interaction with Rem examined by immunoblotting with biotin-Flag 
antibody. 5 μg cell lysate was immunoblotted with bio-Flag or anti-HA to determine the 
expression level of Rem or CCT-DS/CCT-DSS1928A, respectively.   
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Figure 3.6 Co-expression of CCT-PX partially recovers L-type current from Rem-
mediated regulation in HIT-T15 cells. 
A, Current-voltage relationships were determined as described in “Chapter 2” for HIT-
T15 cells co-transfected with GFP+3xHA (filled triangles, n=9), GFP+3xHA-CCT-PX 
(filled circles, n=6) or GFP+3xHA-CCT-MD (open squares, n=7) in the presence of 30 
mM Ba2+. B, Current density at 15mV is displayed for experiments in Figure 3.6A.  
There is no significant difference between the treatments.  C. Current density at 15 mV 
from HIT-T15 cells cotransfected with GFP+3xHA (n=9), GFP-Rem+3xHA (n=9), GFP-
Rem+3xHA-CCT-PX (n=13), or GFP-Rem+3xHA-CCT-MD (n=15). The error bars 
represent the standard error of the mean. Analysis of the results by student’s t test 
revealed a significant difference between treatments denoted by single (P<0.05) or double 
(P<0.00005) asterisks. 
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Figure 3.7 Plasma membrane targeting is essential for Rem:CCT association. 
A, In order to determine whether plasma membrane targeting of Rem was necessary for 
CCT interaction, co-immunoprecipitation studies were performed. TsA201 cells were 
transiently co-transfected with plasmids expressing either 3xFlag-tagged Rem, Rem-(1-
265), Rem-(1-265)-KCAAX, or Rem-(1-265)-HCAAX and either empty 
PCDNA3.1+3xHAa vector control or 3xHA-tagged CCT-PX. Co-immunoprecipitation 
was performed with HA antibody as described in “Chapter 2.” 5 μg cell lysate was 
immunoblotted with anti-Flag or anti-HA to determine the expression level of Rem 
proteins or CCT-PX, respectively. B, TsA201 cells were transiently co-transfected with 
plasmids expressing either 3xFlag-tagged Rem-(1-265)-HCAAX or Rem-(1-265)-
HSAAX and either empty pCDNA3.1+3xHAa vector control or 3xHA-tagged CCT-FL. 
Co-immunoprecipitation was performed with HA antibody as described in A. C, TsA201 
cells were transiently co-transfected with plasmids expressing either 3xHA-tagged Rem-
(1-265)-HCAAX or Rem-(1-265)-HSAAX and either empty PCMVT7/F2 vector control 
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or Flag-tagged β1b. Co-immunoprecipitation was performed with Flag antibody as 
described in “Chapter 2” and interaction with Rem proteins examined by immunoblotting 
with biotinylated HA antibody. Immunoprecipitates were blotted for β1b using 
biotinylated Flag antibody. 5 μg cell lysate was immunoblotted with anti-HA to 
determine the expression level of Rem. D. TsA201 cells were transfected with plasmids 
expressing Cav1.2, β1b and either GFP-Rem-(1-265)-HCAAX, GFP-Rem-(1-265)-
HSAAX, or unfused GFP as control. Current was examined using the whole-cell patch 
clamp configuration in the presence of 30 mM Ba2+.       
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Figure 3.8 Localization of green fluorescent protein (GFP)-Rem-(1-265)-HCAAX 
and GFP-Rem-(1-265)-HSAAX. 
TsA201 cells were transfected with plasmids expressing GFP-Rem-(1-265)-HCAAX or 
GFP-Rem-(1-265)-HSAAX. 48 h post transfection cells were examined by confocal 
microscopy.  Note that Rem-(1-265)-HCAAX is enriched at the cell periphery, which is 
consistent with plasma membrane localization. However, Rem-(1-265)-SCAAX displays 
predominant cytosolic localization.      
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Chapter 4. Ca2+/CaM mediates Rem:CCT interaction 
 
4.1 Introduction   
        As discussed in the last chapter, deletion mapping studies indicated that Rem 
directly associates with a region around the CB-IQ region in the CCT-PX (Figure  3.3), 
which is known to contribute to both Ca2+-dependent inactivation (CDI) and Ca2+-
dependent facilitation (CDF) through interaction with Ca2+-bound calmodulin [128, 129, 
138, 148, 188]. Since overexpression of a Ca2+ insensitive CaM mutant disrupts CDI in a 
“dominant-negative manner”, Ca2+-free CaM (ApoCaM) has been proposed to bind CCT-
PX constitutively [128, 129, 132]. Three different sequences within the Cav1.2 C-
terminus have been suggested to contribute to ApoCaM or Ca2+/CaM binding and 
regulation, designated A, CB and IQ [138, 188]. At resting Ca2+ level, Apo-CaM is 
proposed to bind CCT-PX, although the exact binding domain is controversial; it is 
recognized that upon channel opening, the influx of Ca2+ binds CaM tethered at the CCT-
PX very rapidly and initiates a conformational change within the CCT-PX domain. This 
process triggers the development of CDI and the rapid shutdown of channels [138]. A 
recent study by Pitt and colleagues suggests that Ca2+ -bound CaM elicits a 
conformational change within the Cav1.2 C-terminus which promotes its interaction with 
the α1C I-II intracellular linker, resulting in channel inactivation [145]. Indeed, mutation 
of the isoleucine to a glutamate within the IQ domain (IQ to EQ) dramatically disrupts 
CaM binding and abolishes both CDI and CDF [129]. Mutations of other residues in the 
IQ domain which disrupt IQ:CaM association also prevent CDI [131]. While it is still 
under debate whether IQ motif is involved in ApoCaM binding [138, 140, 141], A, CB 
and IQ motif have all been implicated in the tethering of Ca2+-CaM [137, 142-144], 
although the exact binding sites and conformations formed by Ca2+/CaM and CCT appear 
to be dependent on the functional status of the channel [138]. Considering the essential 
role of CB-IQ domain in CaM binding and the development of CDI, it is important to 
determine whether the interaction between Ca2+-bound CaM and the CB-IQ domain 
affects Rem:CCT-PX association and vice versa. If there is an interplay between 
Rem:CB-IQ association and CaM:CB-IQ association, it would be very important to 
determine if Rem alters the inactivation kinetics of CDI. In this chapter, we report that 
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Ca2+/CaM disrupts Rem:CCT-PX binding in vitro, and that this activity is not due to 
direct CaM binding to the Rem C-terminus. Interestingly, overexpresssion of CaM 
partially relieves Rem-mediated L-type calcium channel inhibition and at the same time 
Rem/CaM co-expression slows the kinetics of CDI, indicating that Rem and Ca2+/CaM 
are likely competitors for CB-IQ binding and that Rem, and other RGK proteins, may 
function at endogenous levels of expression as regulators of the kinetics of Ca2+ channel 
inactivation, rather than as complete inhibitors of channel activity.  
        Dr. Robert N. Correll from our lab generated the electrophysiological data for 
Cav1.2+β2a+GFP-Rem-(1-265)-HCAAX+PKH3-CaM shown in Figure 4.4E. I generated 
all of the rest of data shown in Figure 4.1, 4.2, 4.3, 4.4, 4.5, 4.6 and 4.7.  
 
4.2 Results 
 
4.2.1 Ca2+/CaM inhibits Rem:CCT interaction in vitro 
        As described in chapter 3, both CaM and Rem are able to bind CCT-PX near the 
CB-IQ region (Figure 3.3) [138], and CaM is known to associate with the Rem C-
terminus in a Ca2+-dependent manner [44, 159]. Therefore, we reasoned that CaM may 
have an effect on Rem:CB-IQ binding. Since we have previously shown that Rem 
directly interacts with CCT-PX in a nucleotide independent manner (Figure 3.2B), we 
used GST-Rem fusion protein to pull down 35S-labeled CCT-FL or CCT-PX in the 
presence or absence of exogenous CaM. We first tested whether high concentrations of 
Ca2+ or EGTA would affect Rem:CCT binding without adding exogenous CaM to the 
pulldown assay. Compared with GST-Rem:CCT-FL binding in the presence of 5 mM 
EGTA (Figure 4.1, top panel, lane 4), the binding between Rem and CCT-FL was 
modestly decreased by the addition of 2 mM Ca2+ (Figure 4.1, top panel, lane 2). 
However, while the addition of CaM to the binding reaction had no obvious effect on 
Rem:CCT-FL association in the presence of EGTA (Figure  4.1, top panel, lane 8), the 
interaction between Rem and CCT-FL was almost completely inhibited upon the addition 
of 2 mM Ca2+ (Figure  4.1, top panel, lane 6). The same study using GST-Rem and CCT-
PX yielded similar results (Figure 4.1, bottom panel). The fact that exogenous CaM 
disrupted Rem:CCT binding only in the presence of Ca2+ suggests that it is Ca2+-bound 
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CaM that serves to disrupt Rem:CCT association. This result also suggests that direct 
Ca2+-CaM binding to CCT or Rem serves to block Rem:CCT association. The decrease in 
Rem:CCT association in the presence of high concentrations of Ca2+ without the addition 
of exogenous CaM is likely due to the presence of small amounts of CaM within the 
reticulocyte (immature red blood cells) lysate used to generate the in vitro translated 
CCT-FL or CCT-PX proteins.  
        We next asked whether high concentrations of Ca2+ disrupts Rem:CCT association 
when Rem and CCT are co-overexpressed in TsA201 cells. For these studies, the binding 
of 3xHA-tagged CCT-PX to 3xFlag-tagged Rem in the presence of saturating Ca2+ or 
EGTA was determined using co-immunoprecipitaion followed by immunoblot analysis. 
As seen in Figure 4.2, although Rem displayed binding with CCT-PX in the presence of 5 
mM EGTA (Figure 4.2, top panel, lane 4), the binding between Rem and CCT-PX  was 
dramatically decreased in the presence of 2 mM Ca2+ (Figure 4.2, top panel, lane 2). 
Transfected cells expressed similar levels of Rem and CCT-PX (Figure 4.2, middle and 
bottom panel), indicating that the loss of binding between Rem and CCT-PX was not the 
result of Ca2+-dependent proteolysis or a transfection artifact. Addition of exogenous 
CaM did not affect the relative binding affinity between Rem and CCT either in the 
presence of 2 mM Ca2+ or in the presence of 5 mM EGTA (data not shown), likely 
because sufficient endogenous CaM is expressed in the tsA201 cells to be saturating. In 
summary, Ca2+/CaM inhibits Rem and CCT association in TsA201 cells. 
 
4.2.2 Ca2+/CaM mediated-Rem:CCT association is not due to Ca2+/CaM binding to 
the Rem C-terminus 
        Since Ca2+/CaM is known to interact with both the CB-IQ domain and regions prior 
to the CB-IQ within the CCT to modulate channel auto-regulation [137, 138, 142-144], 
and the Rem C-terminus interacts with CaM in a Ca2+-dependent manner [44, 56, 159], 
we next asked whether Ca2+/CaM-mediated blockade of Rem:CCT association is the 
result of Ca2+/CaM binding to the CCT-PX or the Rem C-terminus. In order to 
distinguish between these two possibilities, we made use of two chimeric proteins in 
which the C-terminus of K-Ras4B and H-Ras were fused to Rem-(1-265), which were 
described in chapter 3 [56]. Whereas the K-Ras4B-CAAX motif shares several properties 
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with the Rem C-terminus, including a polybasic domain capable of PI lipid-meditated 
plasma membrane targeting and calmodulin association [60, 189, 190], the H-Ras-CAAX 
domain contains a prenylation/palmitoylation membrane localization signal and does not 
bind CaM [189]. Previous studies found that fusion of the CAAX motif from either K-
Ras4B or H-Ras to the C-terminal truncation mutant Rem-(1-265), restored membrane 
localization and L-type Ca2+ channel regulation [56]. In chapter 3 we demonstrated that 
while Rem-(1-265) fails to associate with the CCT-PX, fusion of the CAAX motif from 
K-Ras4B or H-Ras to Rem-(1-265) C-terminus restored Rem:CCT-PX binding (Figure 
3.7A). In order to examine whether Rem-(1-265)-KCAAX or Rem-(1-265)-HCAAX 
binds to Ca2+/CaM, tsA201 cells were transfected with mammalian expression vectors 
encoding either 3xFlag-Rem, 3xFlag-Rem-(1-265), 3xFlag-Rem-(1-265)-KCAAX, 
3xFlag-Rem-(1-265)-HCAAX, or empty p3xFlag-CMV-10 vector as a control, and 
lysates from these cells were subjected to CaM sepharose pulldown. As shown in Figure 
4.3A, only WT-Rem and Rem-(1-265)-KCAAX displayed CaM binding, consistent with 
our previously published work, CaM binding was disrupted by truncation of the Rem C-
terminus [56]. Rem-(1-265)-HCAAX did not show Ca2+/CaM binding, which is also 
consistent with the previous studies indicating that H-Ras does not bind CaM [189].   
        We next examined whether high concentrations of Ca2+ still disrupted the interaction 
between CCT-PX and Rem-(1-265)-KCAAX or Rem-(1-265)-HCAAX. As seen in 
Figure 4.3B, Rem, Rem-(1-265)-KCAAX, and Rem-(1-265)-HCAAX were all capable of 
CCT-PX binding in the absence of Ca2+ (Figure 4.3B, lanes 2, 4 and 6), but did not 
associate with CCT-PX in the presence of 2 mM Ca2+ (Figure 4.3B, lanes 1,3,and 5). 
These data indicate that the Ca2+/CaM mediated blockade of Rem:CCT association is not 
due to Ca2+/CaM binding to the Rem C-terminus.  
 
4.2.3 Overexpression of CaM partially recovers L-type current from Rem-mediated 
inhibition in tsA201 cells 
      Since Ca2+/CaM-mediated Rem:CCT association is not due to Ca2+/CaM binding to 
the Rem C-terminus (Figure 4.3), we reasoned that Ca2+/CaM competes with Rem for 
CCT-PX binding. CCT association appears to play an important role in Rem-mediated 
channel regulation (Figure 3.6), and we reasoned that saturating levels of CaM should 
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compete with Rem for CCT-PX binding, resulting in at least partial relief of Rem-
mediated channel inhibition. In order to test this hypothesis, we next examined the effect 
of CaM overexpression on Rem-dependent channel regulation in transfected tsA201 
cells. We first evaluated the effect of CaM overexpression using 30 mM Ba2+ as the 
charge carrier. Peak currents elicited from tsA201 cells expressing Cav1.2+FLAG-
β2a+GFP+pKH3-CaM (Figure 4.4A, black square, -18.6±6.1 pA/pF, n=11 and Figure 
4.4C) were not significantly different from those obtained in the absence of co-expressed 
CaM [Cav1.2+FLAG-β2a+GFP+pKH3] (Figure 4.4A, green diamond, -12.3±2.4 pA/pF, 
n=11 and Figure 4.4C), indicating that CaM overexpression alone does not modulate L-
type Ca2+ channel current density. Overexpression of CaM did not alter the relationship 
between the IBa density and test pulse potential (Figure 4.4A). Unsurprisingly, co-
expression of GFP-Rem was capable of generating complete current blockade in the 
presence of 30 mM Ba2+ (Figure 4.4A, black unfilled circle, -0.3±0.4 pA/pF, n=6 and 
Figure 4.4C). Importantly, co-expression of pKH3-CaM was able to partially relieve 
Rem-mediated blockade of L-type ionic current (Figure 4.4 A, C). In these experiments, 
CaM overexpression resulted in peak current densities of >3.5 pA/pF (Figure 4.4A, red 
triangle, -3.6±1.2 pA/pF, n=12 and Figure 4.4C), which is ~19% of the peak current 
density elicited in the absence of Rem overexpression. Although the average peak current 
densities generated from Cav1.2+FLAG-β2a+GFP-Rem+pKH3 and Cav1.2+FLAG-
β2a+GFP-Rem+pKH3-CaM transfection were not found to be statistically different, 7 out 
of 12 cells transfected by Cav1.2+FLAG-β2a+GFP-Rem+pKH3-CaM generated 
detectable Ca2+ current (peak current density < -1.5 pA/pF) while only 1 out of 6 cells 
transfected by Cav1.2+FLAG-β2a+GFP-Rem+pKH3 generated detectable Ca2+ current 
(peak current density = -2.3 pA/pF). We next tested the effect of CaM overexpression on 
Rem-mediated channel inhibition using 30 mM Ca2+ as the charge carrier. Peak current 
density elicited from the overexpression of Cav1.2+FLAG-β2a+GFP+pKH3-CaM (Figure 
4.4B, green circle, -6.9±1.6 pA/pF, n=20 and Figure 4.4D) was not statistically different 
from those seen following the overexpression of Cav1.2+FLAG-β2a+GFP+pKH3 (Figure 
4.4B, black square, -6.3±1.9 PA/pF, n=11 and Figure 4.4D), suggesting that CaM 
overexpression alone does not modulate L-type Ca2+ channel current density. 
Overexpression of CaM also did not alter the relationship between the ICa density and test 
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pulse potential (Figure 4.4B). As expected, co-expression of GFP-Rem resulted in a 
complete blockade of current expression in this system (Figure 4.4B, black triangle, -
0.1±0.2 pA/pF, n=8 and Figure 4.4D). However, co-expression of Rem and pKH3-CaM 
resulted in >3 pA/pF peak inward current (Figure 4.4B, red diamond, -3.0±0.7 pA/pF, 
n=16 and Figure 4.4D), which was found to be significantly different from the average 
current density elicited from the Cav1.2+FLAG-β2a+GFP-Rem+pKH3 transfection 
(Figure 4.4D) (p<0.01, Kruskal-Wallis test followed by a post hoc Dunn’s test). Thus, 
expression of CaM results in a partial restoration of ICa,L, with CaM co-expression 
generating 43% of the peak current elicited in 30 mM Ca2+ in the absence of Rem (Figure 
4.4B and 4.4D).  
        In order to examine whether CaM-modulated Ca2+ current recovery is due to 
Ca2+/CaM binding to the Rem C-terminus, we overexpressed GFP-Rem-(1-265)-
HCAAX, a chimeric Rem protein which is unable to bind Ca2+/CaM (Figure 4.3A), but is 
capable of potent channel inhibition [56], with pKH3-CaM in tsA201 cells. Consistent 
with our previously published work [56], GFP- Rem-(1-265)-HCAAX potently reduced 
ionic current when co-expressed with Cav1.2+FLAG-β2a+pKH3 in tsA201 cells (Figure 
4.4E, black unfilled squares, -0.7±0.4 pA/pF, n=8). However, whole cell peak currents 
elicited in the presence of pKH3-CaM and GFP-Rem-(1-265)-HCAAX (Figure 4.4E, red 
diamond, -6.0±1.8 pA/pF, n=10) were indistinguishable from currents elicited following 
the expression of Cav1.2+FLAG-β2a+GFP+pKH3-CaM in 30 mM Ca2+ (Figure 4.4E, 
green circle, -6.9±1.6 pA/pF, n=20). These data suggest that CaM-modulated Ca2+ 
current recovery from Rem blockade is not due to Ca2+/CaM binding to the Rem C-
terminus. Although we do not have a straightforward way to measure the expression 
levels of Rem and Ca2+ channel subunits in individual cell, the average expression levels 
detected from whole cell lystes indicate that overexpression of CaM does not alter the 
expression level of Rem or channel subunits (Figure 4.5). In summary, CaM 
overexpression partially relieves Rem-mediated L-type Ca2+ current inhibition with either 
Ba2+ or Ca2+ as the charge carrier.  
 
4.2.4 Rem alters the kinetics of calcium-dependent channel inactivation  
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         It is well established that Ca2+/CaM binding to the CCT triggers the generation of 
CDI [138]. Since Rem has also been shown to interact with the CCT-PX around the CB-
IQ domain and overexpression of CaM partially relieves Rem-mediated L-type Ca2+ 
channel inhibition (Figure 4.4A, B), we next asked whether Rem alters the kinetics of 
voltage-dependent inactivation (VDI) or calcium-dependent inactivation. Figure 4.6A 
shows the superimposed representative time course of the IBa generated during 300 ms 
test pulses to +5 mV from Vh=-80 mV (holding potential) from the indicated transfection 
experiments; all of the current traces were normalized in order to facilitate the kinetics 
comparison. At 600 ms after the onset of the depolarization, ∼70% of the peak current 
remains for Cav1.2+FLAG-β2a+GFP+pKH3 transfection, and neither CaM nor GFP-Rem 
has an effect on inactivation kinetics of VDI (Figure 4.6C). Figure 4.6B shows the 
superimposed representative time course of the ICa generated during 300 ms test pulses to 
+20 mV from Vh=-80 mV (holding potential) from the indicated transfection 
experiments. In order to examine the effect of overexpressed CaM or Rem on the 
inactivation kinetics of CDI, individual traces of current elicited from different 
experimental conditions in the presence of 30 mM Ca2+ were fitted with a double-
exponential equation as described in Chapter 2 and the time constants of inactivation 
(tau) were then derived (Figure 4.6D). The value of taufast provides a way to determine 
the rate of Ca2+-dependent inactivation. As seen in Figure 4.6D, expression of CaM in 
tsA201 cells did not alter the inactivation kinetics for CaV1.2+FLAG-β2a in the 
depolarizing potentials between 0 mV to 40 mV, which is consistent with previous 
studies [126, 128]. However, inactivation kinetics following overexpression of 
Cav1.2+Flag-β2a+GFP-Rem+pKH3-CaM displayed a statistically significant difference at 
depolarizing potentials from 0 mV to 30 mV (* P<0.05; ** P<0.00005; Student’s t-test). 
Indeed, the average taufast value increased following Rem and CaM co-expression (Figure 
4.6D, red circles, 63.59±4.49 ms, n=8) by 64% when compared to cells expressing CaM 
alone (Figure 4.6D, black squares, 38.83±2.11 ms, n=12) at 20 mV, which is the 
depolarizing potential corresponding to the peak current. Since the average peak current 
density derived from the overexpression of Rem and CaM is about 43% of the peak 
current elicited in the absence of Rem, we plotted the inactivation constant taufast against 
the peak current density measured at 20 mV from individual cells in the presence or the 
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absence of Rem overexpression (Figure 4.7) and compared the values of taufast from these 
two conditions in a similar range of peak current density values. As seen in Figure 4.7, 7 
out of 8 individual values of taufast derived from the transfection of Cav1.2+FLAG-
β2a+GFP-Rem+pKH3-CaM were larger than those derived from the transfection of 
Cav1.2+FLAG-β2a+GFP+pKH3-CaM (<10pA/pF), demonstrating that the significant 
difference in inactivation kinetics between the two experimental conditions is not due to a 
difference in average current densities. The difference in inactivation kinetics seen 
following Rem and CaM co-expression argues that Rem alters the kinetics of Ca2+/CaM-
mediated channel inactivation by altering the rate of CDI. In summary, overexpression of 
Rem significantly slows the inactivation kinetics of CDI, indicating that Rem co-
expression modulates the process of Ca2+-dependent channel inactivation.   
 
4.3 Discussion  
        In this chapter, we provide additional data to substantiate the importance of the 
Rem:CCT interaction to Rem-mediated L-type Ca2+ channel regulation by demonstrating 
an interplay between Rem:CCT-PX association and Ca2+/CaM:CCT-PX binding. First of 
all, we demonstrate that Ca2+/CaM inhibits Rem:CCT-PX association in vitro (Figure 4.1 
and 4.2). While CaM has been shown to interact with the RGK C-terminus in a Ca2+-
dependent manner [17, 46, 55, 159, 191], this association appears to be critical for Gem 
and Rad [44, 55], but not for Rem [44, 159] and Rem2 [46]-mediated Ca2+ channel 
inhibition. The reason for this discrepancy is not clear, although the ability of CaM-free 
Rem and Rad to sequester Cavβ subunits in the nuclear has been proposed to be the 
mechanism [44]. While Ca2+/CaM is capable of inhibiting Rem:CCT association, this 
inhibition does not appear to rely upon Ca2+/CaM binding to the Rem C-terminus since 
the chimeric CaM binding null protein Rem-(1-265)-HCAAX is also subject to 
Ca2+/CaM regulation (Figure 4.3B). This is further supported by our electrophysiology 
studies in which CaM overexpression completely blocked Rem-(1-265)-HCAAX-
mediated L-type Ca2+ channel inhibition when Ca2+ was used as the charge carrier 
(Figure 4.4E). Consistent with previous studies [44, 159], these results indicate that 
Ca2+/CaM binding to the Rem C-terminus is not essential for Rem-mediated calcium 
channel inhibition. 
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         Since Ca2+/CaM has been shown to disrupt Rem:CCT-PX binding in vitro (Figure 
4.1 and 4.2), it was hypothesized that CaM overexpression would relieve Rem-mediated 
VDCC inhibition. Indeed, CaM overexpression was shown to partially reverse Rem-
mediated L-type Ca2+ channel inhibition when either Ba2+ or Ca2+ was used as the charge 
carrier (Figure 4A, B). It is surprising that CaM overexpression also partially relieved 
Rem-mediated channel inhibition in 30 mM Ba2+ since high Ca2+ concentrations are 
required to disrupt in vitro Rem:CCT association (Figure 4.1, 4.2). The fact that CaM 
overexpression did not significantly increase the current density (Figure 4.4A, B, C and 
D), or alter the kinetics of CDI (Figure 4.6B, D), suggests that endogenous CaM is not 
limiting with regard to supporting the generation of functional Ca2+ channels in tsA201 
cells. However, upon Rem overexpression, the expression of additional exogenous CaM 
is required to generate partial current recovery (Figure 4.4A, B). It is possible that a 
threshold concentration of CaM is required to disrupt Rem:CCT binding, which is only 
achieved by overexpressing CaM in the presence of overexpressed Rem.  
        Since the CB-IQ region is implicated in CDI, and CaM overexpression partially 
reversed Rem inhibition, we examined the effect of Rem on CDI. Interestingly, it was 
found that co-expression of Rem slows the kinetics of CDI (Figure 4.6B, D), indicating 
that Rem interacts with CCT and modulates the process of Ca2+/CaM-mediated CDI upon 
overexpression in our systems. This is likely because Rem:CCT binding interferes with 
Ca2+/CaM:CCT binding and the Ca2+/CaM-mediated conformational change within the 
CCT domain which is required for the generation of CDI. Furthermore, in addition to the 
CCT-PX region, Ca2+/CaM has also been shown to interact with the N-terminus [125, 
146, 192] of the L-type Cavα1 subunit and this interaction also contributes to the 
generation of CDI [125]. Additional studies will be necessary to determine whether the 
N-terminus of Cavα1 subunit also interacts with Rem and contributes to Rem-mediated 
channel regulation, if this is the case, then whether overexpression of Rem alters the 
interaction between Ca2+/CaM and this region. Although there is no definitive data to 
support this hypothesis, our studies suggest that a likely physiological role of RGK 
proteins is to alter the kinetics of Ca2+ channel inactivation. 
        Our studies indicated that Rem overexpression partially inhibits Ca2+ current 
amplitude in the presence of overexpressed CaM (Figure 4.4A, B) and slows the 
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inactivation kinetics of CDI (Figure 4.6B, D). Since these two processes affect the 
integrated Ca2+ influx in opposing way, if the former process predominates, the overall 
Ca2+ influx would be decreased; on the other hand, if the latter process predominates, the 
overall Ca2+ influx would be increased. In other words, RKG proteins could function as 
channel inhibitors or channel activators. Whether this actually occurs under normal 
physiological conditions is not addressed by the experiments in this chapter. However, 
our studies suggest the possibility that RGK proteins may serve to stimulate Ca2+ currents 
under physiological conditions, and the observed channel inhibition may be an artifact of 
overexpression resulting from a cellular imbalance between Rem and CaM.  
        It has been reported that levels of Rad mRNA and protein are decreased 
significantly in failing human hearts and that Rad expression is decreased significantly in 
murine cardiac hypertrophy models [10], suggesting that Rad may play an important role 
in maintaining normal cardiac function. However, whether endogenous L-type calcium 
channel function is altered and whether the kinetics of CDI is altered in the 
cardiomyocytes of Rad knockout animals has not yet been examined. The generation of 
additional RGK knockout animals will be needed to fully address these important 
questions. If the physiological role of RGK proteins is to alter the kinetics of CDI, as 
what we observed in Figure 4.6B, D for Rem GTPase, we would expect to see a change 
in kinetics of CDI for the L-type Ca2+ channels in cardiomyocytes following RGK 
silencing.  
        In summary, our studies indicate that there is an interplay between Rem:CCT 
association and Ca2+/CaM:CCT association. More importantly, our studies also suggest 
that instead of functioning as a complete inhibitor for VDCCs, Rem may act as an 
endogenous regulator for Ca2+ channel inactivation to slow the shutdown of the Ca2+ 
channels and increase the integrated Ca2+ influx in normal physiology. 
 
 
 
 
Copyright © Chunyan Pang 2008 
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Figure 4.1 Ca2+/CaM inhibits Rem:CCT association in vitro. 
Recombinant GST or GST-Rem proteins coupled to GST beads were preloaded with 
GDP, incubated with 35S-labeled CCT-FL (top panel) or CCT-PX (bottom panel) in the 
presence of 2 mM Ca2+ or 5 mM EGTA with or without adding of 2 μg CaM for 3 h at 
4°C. The GST beads were then pelleted and washed as described in chapter 2. The bound 
fractions were subjected to SDS-PAGE, and the dried gel was exposed to film for 16-72h. 
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Figure 4.2  High concentration of Ca2+ inhibits Rem:CCT binding in a co-
ovexpression system. 
TsA201 cells were transiently co-transfected with expression vectors encoding 3xFlag-
tagged Rem and either pCDNA3.1+3xHAa (3xHA empty vector) or 3xHA-tagged CCT-
PX. 48 h post-transfection, cells were harvested, and 0.5 mg cell lysate was subjected to 
immunoprecipitation with anti-HA antibody as described in chapter 2. The entire bound 
fraction was analyzed by immunoblotting with biotin-Flag to detect Rem. 5 μg cell lysate 
was immunoblotted with anti-Flag or anti-HA to determine the expression level of Rem 
or CCT-PX, respectively.   
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Figure 4.3 Ca2+/CaM-mediated Rem:CCT association is not due to Ca2+/CaM 
binding to the Rem C-terminus. 
A, TsA201 cells were transfected with plasmids expressing 3xFlag-Rem, 3xFlag-Rem-(1-
265), 3xFlag-Rem-(1-265)-KCAAX, 3xFlag-Rem-(1-265)-HCAAX or empty p3xFlag-
CMV-10 as a control. 1 mg of lysates were pulled down onto CaM-sepharose beads in 
the presence of 2 mM CaCl2, proteins were released from the beads with two 20 μl 
washes of assay buffer containing 5mM EGTA, and the ability of Rem WT, Rem 
truncation, or Rem chimeric proteins to associate with CaM was examined by 
immunoblotting with anti-Flag M2 monoclonal antibody. B, TsA201 cells were 
transiently co-transfected with expression vectors encoding 3xHA-tagged CCT-PX and 
3xFlag-tagged Rem, 3xFlag-tagged Rem-(1-265)-KCAAX, or 3xFlag-tagged Rem-(1-
265)-HCAAX. The ability of 3xHA-tagged CCT-PX to interact with either 3xFlag-Rem 
or the indicated Rem chimeric proteins was determined by co-immunoprecipitation 
analysis as described in chapter 2. 5 μg cell lysate was immunoblotted with anti-HA or 
anti-Flag to detect CCT-PX or the indicated Rem proteins, respectively.  
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Figure 4.4 Overexpression of CaM partially recovers L-type current from Rem-
mediated inhibition in tsA201 cells.  
A, TsA201 cells were transfected with the indicated plasmids, and the current was 
examined in the presence of 30 mM Ba2+ using the whole-cell patch clamp configuration. 
B, TsA201 cells were transfected with the indicated plasmids, and the current was 
examined in the presence of 30 mM Ca2+ using the whole-cell patch clamp configuration.  
C, Current density at +5 mV from A. A significant difference (p<0.01, Kruskal-Wallis 
test followed by a post hoc Dunn’s test) between treatments is denoted by asterisk. D, 
Current density at +20 mV from B. A significant difference (p<0.01, Kruskal-Wallis test 
followed by a post hoc Dunn’s test) between treatments is denoted by asterisks. E, CaM-
modulated Ca2+ current recovery from Rem blockade is not due to Ca2+/CaM binding to 
the Rem C-terminus. TsA201 cells were transfected with the indicated plasmids, and the 
current was examined in the presence of 30 mM Ca2+ using the whole-cell patch clamp 
configuration. 
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Figure 4.5 Overexpression of CaM does not change the average expression levels of 
Ca2+ channel subunits or GFP-Rem.  
TsA201 cells were transiently transfected with Cav1.2, Flag-β2a, GFP-Rem, and pKH3-
CaM or pKH3 as the control. 48 hrs after the transfection, cell lysate was immunoblotted 
with anti-Cav1.2, biotin-Rem or anti-HA antibody to detect Cav1.2, GFP-Rem, or CaM 
protein, respectively. Flag--β2a was detected by immunoprecipitating cell lysate using 
anti-Flag coupled to protein G beads and then immunoblotting the released proteins with 
biotin-Flag.   
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Figure 4.6 Overexpression of Rem alters the kinetics of CDI. 
A, Representative IBa traces recorded from tsA201 cells transfected with the indicated 
plasmids for Vtest +5 mV. B, Representative ICa traces recorded from tsA201 cells 
transfected with the indicated plasmids for Vtest +20 mV. C, Residual fraction of currents 
(r600) remaining at the end of the test pulses for Vtest +5 mV in the presence of 30 mM 
Ba2+. There are no significant differences among the different transfection conditions. D, 
Overexpression of Rem slows the inactivation kinetics of CDI. During a 800 ms test 
pulse to a series of depolarizing potentials ranging from 0 mV to 40 mV, the inactivation 
time constant tau was measured by fitting the inactivating components of the current 
traces to the following equation: i(t) =A1* exp( t /taufast) + A2 * exp( t/tauslow) + C. The 
fast inactivation component taufast at the different transfection conditions are plotted 
against the corresponding depolarizing potentials. The error bars represent the standard 
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error of the mean. Analysis of the results by student’s t test revealed a significant 
difference between treatments denoted by single (P<0.05) or double (P<0.00005) 
asterisks. Statistics comparison are between the transfection of Cav1.2+FLAG-β2a+GFP-
Rem+PKH3-CaM (red cycles) and the transfection of Cav1.2+FLAG-β2a+GFP+PKH3-
CaM (black squares). 
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Figure 4.7 Relations between the fast component of the time constant of inactivation 
(taufast) and peak current density for the transfection of Cav1.2+FLAG-β2a+GFP-
Rem+PKH3-CaM and Cav1.2+FLAG-β2a+GFP+PKH3-CaM. 
Taufast derived from fitting of individual traces of current as described in chapter 2 were 
plotted against the peak current density measured at 20 mV obtained from the 
overexpression of Cav1.2+FLAG-β2a+GFP-Rem+PKH3-CaM (red cycles) or the 
overexpression of Cav1.2+FLAG-β2a+GFP+PKH3-CaM (black squares). 
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Chapter 5. Summary and Future Studies 
 
5.1 Summary of the major findings 
 
5.1.1 Rem:CCT binding represents another important molecular determinant in 
Rem-mediated L-type calcium channel regulation 
        When I started my project, our lab and others had shown that two molecular 
determinants played important roles in RGK-mediated Ca2+ channel regulation. The first 
was the involvement of RGK:Cavβ binding in RGK-mediated calcium channel regulation 
[163]. All of the four isoforms of Cavβ subunits have been shown to be able to bind RGK 
proteins [55, 57, 58, 155, 156, 158], and previous studies had indicated that RGK:Cavβ 
binding was required to generate channel blockade [55, 57, 58, 158]. At least three lines 
of evidence have been generated in support of this statement. First, although Rem 
overexpression can partially inhibit L-type calcium current derived from the 
overexpression of Cavα1 alone in HEK293 cells [57], complete inhibition of Ca2+ current 
is observed when Cavβ subunit is co-overexpressed [57]. Secondly, the putative Rad 
dominant-negative mutant RadS105N, which is unable to bind Cavβ subunit [158], can not 
inhibit Ca2+ channel activity [158]. Finally, RGK proteins can not regulate the functions 
of T-type channels [52, 58], which do not require accessory Cavβ subunits [71]. However, 
studies from our group and others also indicated that Cavβ binding alone is not sufficient 
to block the channel activity [56, 162], which led to the identification of the second 
molecular determinant in channel inhibition: the targeting of RGK protein to the plasma 
membrane [163]. Although RGK proteins do not contain canonical lipid modification 
motif in their C-terminus [51], the polybasic residues located at their C-terminus have 
been found to direct plasma membrane localization by interacting with negatively 
charged PIP lipids [56, 60, 61]. The importance of plasma membrane localization in the 
generation of channel inhibition is highlighted by the observation that RGK proteins fail 
to inhibit channel function when they are localized to the cytosol following truncating 
their C-terminus. Importantly, these C-terminal truncation mutant proteins are still 
capable of interacting with Cavβ subunits [52, 56, 58, 162]; and the ability of the 
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truncation mutants to inhibit channel function is restored by the addition of plasma 
membrane-targeting motifs [52, 56, 162].   
        A recent study indicated that the phosphorylation status of Ser1928 within the 
Cav1.2 C-terminus may affect Rem-mediated Ca2+ channel inhibition through a protein 
kinase A signaling pathway [57], suggesting that the Cavα1 subunit may also contribute to 
Rem-mediated channel regulation. We extended these findings by demonstrating a direct 
interaction between Rem and CCT-PX (Figure 3.2B). As an important control, Rem does 
not interact with the CCT from T-type channels (Figure 3.1D), which do not undergo 
RGK-mediated channel regulation [52, 58]. Deletion mapping studies indicated that the 
conserved CB-IQ domain is required for Rem:CCT-PX association (Figure 3.3B), a 
region known to play an essential role in modulating channel self-regulation, including 
CDI and CDF, through the interactions of Ca2+/CaM with this domain [128, 129, 131, 
140, 148]. We also found that Rem is capable of binding both of the proximal and distal 
CCT (Figure 3.1B), although CCT-DS is not essential for Rem-mediated channel 
inhibition (Figure 3.5A). Moreover, similar binding patterns are conserved in another two 
RGK proteins, Rem2 and Rad (Figure 3.4A, B); indicating that the CCT represents a 
common binding partner for the RGK GTPase subfamily. Our studies have generated two 
lines of evidence to support the importance of Rem:CCT-PX binding in the generation of 
channel inhibition. First, overexpression of CCT-PX partially reversed Rem-mediated L-
type calcium channel inhibition in HIT-T15 cells (Figure 3.6C), presumably by 
sequestering Rem from binding to the CCT domain in full-length Cavα1 within the mature 
channel complex. Secondly, although Rem:Cavβ binding is dispensable for the plasma 
membrane localization of Rem [56, 162] and channel inhibition [56, 162], Rem:CCT 
binding is well correlated with membrane localization of Rem and more importantly, 
with Ca2+ channel inhibition (Figure 3.7 and 3.8). Therefore, we propose that in addition 
to Cavβ binding and plasma membrane localization, Rem binding to the CCT-PX near the 
CB-IQ domain is also required for channel regulation (Figure 5.1A). Although our 
studies suggest that Rem:CCT-PX binding may represent an unappreciated molecular 
determinant which is also critical to Rem-mediated calcium channel regulation, direct 
evidence in support of this hypothesis is lacking and requires additional investigation. 
 81
The approach which can be used to examine this hypothesis will be discussed in section 
5.2.1.  
      
5.1.2 Ca2+/CaM mediates Rem:CCT association and Rem overexpression alters the 
kinetics of calcium-dependent inactivation 
        Another important finding from these studies is that Ca2+/CaM may regulate 
Rem:CCT association (Figures 4.1, 4.2). Both ApoCaM and Ca2+/CaM have been shown 
to interact with CB-IQ region and regions near CB-IQ to modulate channel self-
regulation, including CDI and CDF [128, 129, 131, 140, 148], two opposite processes in 
terms of regulating channel activity [138]. The fact that ApocaM is pre-tethered to the 
CCT-PX enables the rapid response of CaM to local changes in Ca2+ concentration [128]. 
Upon channel activation, Ca2+ fluxing into the cells binds to CaM preassociated within 
CCT-PX [128, 137] and initiates channel inactivation in milliseconds [131]. In the resting 
state, the cytosolic Ca2+ concentration in many cell types is thought to be around 100-200 
nM [193-195]; Opening of the Ca2+ channel generates a spatial Ca2+ gradient, within a 
few nanometers of the channel pore, the concentration of Ca2+ is estimated to be around 
10-100 μM upon channel activation [196, 197]. Since CaM-mediated inhibition of 
Rem:CCT association appears to depend upon high Ca2+ concentration in vitro (Figure 
4.1), it will be important to determine whether channel activation alters Rem-mediated 
regulation. This can be examined by titrating the expression levels of Rem in xenopus 
oocyte, which has been shown to be feasible [156] and then test if the different levels of 
channel activity mediate the Rem-dependent alteration in CDI. As shown in Figure 5.1A, 
we proposed that when Ca2+ concentration near the ion pore is low (for example, at 
resting state), Rem is able to interact with Cavβ which is tethered to the I-II loop of the 
Cavα1 subunit and CCT-PX around the CB-IQ domain at the same time, the formation of 
I-II loop/Cavβ/Rem/CCT is required to generate channel regulation. However, whether 
Rem functions as a potent inhibitor for Ca2+ channel activity in native systems is 
questionable since dramatic or complete inhibition is only observed upon Rem 
overexpression. ApoCaM, however, is associated with CCT-PX including the domain A. 
Whether CB-IQ domain is also involved in ApoCaM binding is not clear since the 
involvement of IQ domain in ApoCaM association is controversial [138]. When Ca2+ 
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concentration near the ion pore is higher than a certain threshold, Ca2+ binds to the 
ApoCaM which is preassociated with the CCT-PX and Ca2+-bound CaM initiates a 
conformation change in the CCT domain. Since Ca2+/CaM has a higher affinity for CB-
IQ binding, it disrupts the Rem:CCT-PX association. In this process, Rem slows the 
occurrence of Ca2+/CaM-mediated channel closing. Ca2+/CaM has also been shown to 
interact with N-terminus of Cavα1 subunit [125, 146] and this association contributes to 
the generation of CDI [125]. However, whether Rem alters the interaction between 
Ca2+/CaM and the N-terminus of Cavα1 or whether there is an interaction between the N-
terminus and C-terminus of Cavα1 is currently unkown. The following observations 
provide more evidence to support the model illustrated in Figure 5.1B. Firstly, 
overexpression of CaM partially recovered Rem-mediated Ca2+ channel inhibition 
(Figure 4.4). Secondly, the kinetics of CDI mediated by Ca2+/CaM binding to CCT-PX 
was altered in the presence of overexpressed Rem (Figure 4.6B, D), indicating that 
Rem:CCT binding interferes with the Ca2+/CaM-mediated CCT association and the 
ensuing conformational change in this region. 
        The hypothesis that Rem acts to modulate channel activation/inactivation, rather 
than serving as an absolute inhibitor of Ca2+ channel activity is a radical departure from 
all previous models of RGK-mediated channel control [25, 44, 46, 47, 52, 55, 57, 58, 
155, 156, 158, 163]. While it is well established that RGK blocks ionic Ca2+ current upon 
overexpression [163], it should be pointed out that overexpression may not be the best 
way to investigate the physiological roles of RGK proteins (section 5.2.2). Furthermore, 
although our data suggest that the existence of the two different functional states shown 
in Figure 5.1, it does not consider the complex intracellular environment and does not 
describe the physiological function of RGK proteins at endogenous expression levels.  
Indeed, it remains to be established whether RGK proteins predominantly function as 
endogenous inhibitors of Ca2+ channel activity, to modulate the kinetics of channel 
gating, or to operate in a novel regulatory cascade. It would appear that at non-
physiological levels of expression, Rem may act as an inhibitor of channel activity, but 
that restoration of a single binding partner, namely CaM, has the ability to profoundly 
alter Rem-mediated channel regulation. In native systems, we suggest that it is necessary 
to consider RGK proteins as regulators that modulate channel opening probability instead 
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of absolute channel blockers, with the possibility that RGK GTPases may function to 
alter the kinetics of channel inactivation. The examination of these notions will require 
the generation of RGK knockout animals or RGK knockdown cells systems. Since if 
endogenous levels of RGK proteins inhibit channel current amplitude or slow the kinetics 
of channel inactivation for L-type Ca2+ channels, knockdown of RGK proteins in native 
systems would increase the Ca2+ current amplitude or enhance the  kinetics of channel 
inactivation. 
        In summary, although it is not yet clear whether alteration of the kinetics of CDI 
represents an important functional role for Rem in normal physiology, those studies point 
out the possibility that there is dynamic interplay among Ca2+/CaM, CCT and Rem. 
Instead of functioning as a complete inhibitor to suppress ionic current, Rem may act as 
an endogenous regulator for channel inactivation machinery.  
 
5.2 Future directions    
 
5.2.1 To determine the detailed molecular mechanisms underling RGK-mediated 
calcium channel regulation 
        In addition to Cavβ binding and plasma membrane localization of RGK GTPases, 
our studies suggest that RGK:CCT binding is an important molecular determinant in 
generating Ca2+ channel inhibition upon overexpression (Figure 3.6 and Figure 3.7). 
However, the definitive evidence to support the essential role of Rem:CCT binding in 
Rem-mediated channel regulation is still lacking. Further studies need to be performed in 
order to confirm this hypothesis. The most direct experimental approach would be to 
generate a CB-IQ/CCT domain mutant in the context of Cav1.2-(1-1905) that displays 
normal channel function, but fails to associate with Rem. If this CaVα1 mutant is still 
responsive to Rem-mediated Ca2+ current suppression, then Rem:CCT association is not 
required for channel inhibition. However, if this mutant is resistant to Rem-mediated 
inhibition, then it can be concluded that Rem:CCT association is likely critical to 
generating channel inhibition. Since the CB-IQ domain plays essential roles in channel 
function and mutation of single amino acid in this region can readily alter channel 
inactivation kinetics [129, 145] or abolish Ca2+ ionic current [198], data generated from 
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these mutation studies will need to be carefully controlled and interpreted with caution. A 
similar approach can be used to generate a CCT binding null Rem mutant, which 
maintains Cavβ binding and plasma localization, but fails to associate with CCT. Again, it 
should be aware that mutations in Rem, especially in the core domain can also easily 
destabilize or interfere with the proper folding of the protein, therefore, their nucleotide-
binding properties and the ability to interact with other known binding partners should be 
also examined. 
        Our data suggest that RGK proteins are subject to regulatory mechanisms to allow 
control over their ability to modulate Ca2+ channel activity. However, little is known 
concerning these potential regulatory pathways, and several questions must be addressed 
before this important issue can be tackled. First, what is the molar ratio between RGK 
proteins and L-type Ca2+ channel complex located at the plasma membrane in different 
endogenous systems? A limitation to these studies is the lack of effective antibody 
reagents, both toward the RGK GTPases, but also to many components of L-type 
channels. Secondly, are RGK proteins constitutively tethered to the Cavβ subunits and do 
they always reside with mature channel complexes at the plasma membrane? Thirdly, 
what is the relationship between Rem:Cavβ binding and Rem:CCT binding? Although we 
propose that Cavβ serves as a scaffolding molecule to promote the formation of a stable 
RGK-Cavβ-AID complex, which in turn interacts with the CB/IQ region of the CCT to 
promote channel regulation (Chapter 3.3), the definitive supporting data for this model is 
still lacking. In addition to ApoCaM, Ca2+/CaM and Rem, Cavβ has also been 
demonstrated to interact with the CB-IQ domain [199]. The fact that Rem/CCT-PX/Cavβ 
can interact with each other greatly enhances the complexity of those interactions and 
thwarts efforts to clarify the detailed molecular mechanisms underling those interactions. 
The resolution of these questions may need extensive mapping studies facilitated by 
mutagenesis analysis to generate mutants which lose binding to one of the partner but 
maintain association to the other.  
        It has been shown that CaM interacts with additional intracellular domains of the 
Cavα1 subunit in addition to the CCT, including the N-terminus [125, 146, 192] and the I-
II loop [137] of the L-type Ca2+ channel α1 subunit. The possibility that CaM binding to 
those regions contributes to the reversal of Rem-mediated channel inhibition needs to be 
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investigated. Indeed, it remains to be determined whether any additional intracellular 
domains of the Ca vα1 subunit in addition to CCT are capable of RGK binding.  
 
5.2.2 To explore the physiological functional roles of RGK proteins in native systems 
        Although it is well established that RGK proteins function as potent negative 
regulators to inhibit HVA Ca2+ channel activity upon overexpression in either native or 
heterologous systems [25, 44, 46, 47, 52, 55, 57, 58, 155, 156, 158, 163], the 
physiological roles of RGK proteins at normal expression levels in native systems remain 
poorly understood. It must be pointed out that overexpression may not be the best 
approach to studying the physiological role of RGK proteins in terms of Ca2+ channel 
regulation for the following reasons. First, in native systems including heart, pancreas, 
and brain where L-type calcium channels are expressed, those channels can be activated 
properly in response to membrane depolarization although endogenous RGK proteins are 
also expressed in those tissues. Thus, it appears that either RGK proteins are expressed at 
cellular levels which do not allow association with all channel complexes, that secondary 
regulatory processes limit the extent of Rem association with functional channels, or that 
RGK proteins do not act as inhibitors of channel function, but instead play a more subtle 
role perhaps by altering channel gating as suggested by our recent studies. Secondly, it 
has been reported that RGK proteins inhibit Ca2+ current amplitude in a dose-dependent 
manner [156]. The fact that increasing expression levels of RGK proteins result in 
decreasing Ca2+ ionic current suggests that in native systems, RGK activity may be 
inhibited by a negative regulator(s). Overexpression of RGK proteins may saturate this 
regulatory factor(s), which leads to complete inhibition of the channel activity seen in the 
overexpression studies. Recent studies using transgenic mice, especially Rad transgenic 
mice have started to demonstrate the physiological functions of RGK proteins. Rad 
knockout mice have been generated and those mice were found more susceptible to 
cardiac hypertrophy, possibly correlated with increased CaMKII activity in their 
cardiomyocytes [10]. However, this study failed to examine cardiomyocytes using EP 
methodology, and it will be important to determine whether Rad loss affects the 
inactivation kinetics of L-type calcium channels. Since CaMKII can regulate the 
extraction-contraction coupling in the heart [200], in part through enhancing Ca2+ current 
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by binding to CCT-PX involving the CB-IQ region through a process named calcium-
dependent facilitation (CDF) [148, 201, 202], it will also be interesting to examine 
whether RGK proteins and CaMKII compete for CCT-PX binding and if RGK can alter 
CDF. Transgenic mice overexpressing dominant-negative mutant of Rad displayed a long 
QT interval and demonstrated increased propensity for diverse forms of arrhythmias 
under both resting and stimulated conditions [11], indicating that Rad, and maybe other 
RGK proteins, play very important roles in maintaining normal cardiomyocyte function. 
Although increased numbers of Cavα1 subunits at the plasma membrane in the ventricular 
cardiomyocytes of the dominant-negative Rad transgenic mice has been suggested to 
contribute to the altered cardiac function [11], the detailed molecular mechanisms that 
underlie this increased Ca2+ channel activity await more investigation.  
        Although our studies indicate that Rem might involve in alter the kinetics of CDI 
(Figure 4.6B, D), whether it represents the physiological role of RGK proteins is still not 
understood. If the physiological role of RGK proteins is just to slow down the kinetics of 
CDI, then in the simplest model, RGK proteins are actually functioning as Ca2+ channel 
activators instead of inhibitors by increasing the channel mean opening time. However, it 
is also possible that RGK proteins decrease the opening probability of Ca2+ channel, or 
that different RGK protein will have distinct effects on channel gating. Indeed, a recent 
report indicates that Rem2, but not Gem or Rem, accelerates the inactivation kinetics of 
L-type Ca2+ channels [156].. Therefore, it will be important to characterize the ability of 
the individual members of the RGK family to alter channel gating, and also to determine 
whether the composition of the channel complex may contribute to the nature of the 
regulation. Since four different subtypes of L-type Ca2+ channels and four different β 
subunits (β1-β4) have been identified [71], it will be necessary to determine if RGK 
proteins alter the channel gating in a similar way for the different combinations of Cavα1 
and Cavβ subunits.    
        In summary, we report here that CCT-PX serves as another common binding partner 
for RGK GTPases (Figure 3.1, 3.4), and also demonstrate the importance of Rem:CCT-
PX binding in generating Rem-mediated L-type Ca2+ channel inhibition (Figure 3.6, 3.7). 
Furthermore, our in vitro studies suggest that Ca2+/CaM may regulate Rem:CCT binding 
(Figure 4.1, 4.2). More importantly, our studies suggested that instead of functioning as 
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inhibitors for Ca2+ channel function, RGK proteins may serve as endogenous regulators 
for Ca2+ channel inactivation machinery (Figure 4.6). Therefore, these studies provide 
new insight into the mechanism of RGK-mediated Ca2+ channel regulation and have 
potentially revealed a novel physiological role of the RGK proteins.   
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Figure 5.1 Proposed mechanisms for Rem-mediated L-type Ca2+ channel regulation. 
A, when Ca2+ concentration near the ion pore is low, Rem is capable of interacting with  
Cavβ subunit tethered to the I-II loop of the Cavα1 subunit and also interacts with the 
CB/IQ region of the CCT at the same time. It is questionable whether the formation of I-
II loop/Cavβ/Rem/CCT complex is required to generate channel inhibition in normal 
physiology. ApoCaM is associated with CCT-PX including the domain A. Whether CB-
IQ domain is also involved in ApoCaM binding is not clear since conflicting data have 
been generated in terms of the involvement of IQ domain in ApoCaM association. B, 
When Ca2+ concentration near the ion pore reaches a certain threshold; Ca2+ binds to the 
ApoCaM which is preassociated with the CCT-PX and this binding initiates a 
conformation change in the CCT domain. Since Ca2+/CaM has a higher affinity for CB-
IQ binding, it disrupts the Rem:CCT-PX association. This process slows the kinetics of 
CDI and prolongs the mean opening time of the channel. Ca2+/CaM has also been shown 
to interact with N-terminus of Cavα1 subunit and this association also contributes to the 
generation of CDI for L-type Ca2+ channels. Recently, Ca2+/CaM has been proposed to 
bridge the N- and C-terminus of Cavα1 to trigger the generation of CDI [125]. However, 
whether Rem alters the interaction between Ca2+/CaM and N-terminus of Cavα1 or 
whether there is an interaction between N-terminus and C-terminus of Cavα1 is unknown.  
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